<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://me-pedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Juliajt</id>
	<title>MEpedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://me-pedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Juliajt"/>
	<link rel="alternate" type="text/html" href="https://me-pedia.org/wiki/Special:Contributions/Juliajt"/>
	<updated>2026-04-21T10:16:10Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Bile_salt&amp;diff=52588</id>
		<title>Bile salt</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Bile_salt&amp;diff=52588"/>
		<updated>2019-03-22T19:43:51Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:all&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:Bile Salt.png|thumb|Multiple bile salts surround a fat droplet so that it can be absorbed through the lumen. ]]&lt;br /&gt;
Bile salts are found naturally in bile which is created and secreted by the liver. Bile acids are created from [[cholesterol]] (a type of fat), bile (digestion fluid), and proteins also found in the liver. The purpose of bile salts is to help breakdown and transport lipid compounds out of the intestinal lumen and into the intestinal cells&amp;lt;ref&amp;gt;{{Cite journal|last=Cowen|first=A. E.|last2=Campbell|first2=C. B.|date=1977-12|title=Bile salt metabolism. I. The physiology of bile salts|url=https://www.ncbi.nlm.nih.gov/pubmed/274936|journal=Australian and New Zealand Journal of Medicine|volume=7|issue=6|pages=579–586|issn=0004-8291|pmid=274936}}&amp;lt;/ref&amp;gt;. Some examples of molecules that need bile salts for absorption include cholestrol and fat soluble vitamins. &lt;br /&gt;
&lt;br /&gt;
Bile salts are recycled by the body. In fact, only approximately 5% of the bile salts that are used are excreted&amp;lt;ref&amp;gt;{{Cite web|url=http://www.vivo.colostate.edu/hbooks/pathphys/digestion/liver/bile.html|title=Secretion of Bile and the Role of Bile Acids In Digestion|website=www.vivo.colostate.edu|access-date=2019-03-22}}&amp;lt;/ref&amp;gt;. This metabolism of bile salts is called [https://www.sciencedirect.com/topics/medicine-and-dentistry/enterohepatic-circulation enterohepatic circulation].  &lt;br /&gt;
&lt;br /&gt;
=== Bile Salt Supplementation ===&lt;br /&gt;
Supplementing biles salts [https://www.health.harvard.edu/newsletter_article/do-i-need-to-take-bile-salts-after-gallbladder-surgery has been suggested] for those with biliary sludge (build up of bile) but not for individuals who have had their gallbladder removed. Experts at Harvard Health claim that there is no reason to supplement bile salts as long as you have a healthy functioning liver&amp;lt;ref&amp;gt;{{Cite web|url=https://www.health.harvard.edu/newsletter_article/do-i-need-to-take-bile-salts-after-gallbladder-surgery|title=|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
There may be reasons to consider supplementing with bile salts if you have high cholestrol or have problems absorbing fat soluble vitamins (A,D,E,K). Note that unnecessary supplementation of bile salts has been known to cause diarrhea-- also known as bile acid malabsorption (BAM). BAM is considered to be a major cause of urgency and loose stool in ~1/3 of those with [[irritable bowel syndrome]] (IBS)&amp;lt;ref&amp;gt;{{Cite web|url=https://www.mayoclinic.org/medical-professionals/digestive-diseases/news/identifying-diarrhea-caused-by-bile-acid-malabsorption/mac-20430098|title=|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Bile Salts and the Immune System ===&lt;br /&gt;
Bile salts are capable of communicating with [[macrophages]] (a kind of white blood cell) and facilitating an immune response. Therefore it is possible that those with altered concentrations of bile acids may be at risk for a lack of response to infections&amp;lt;ref&amp;gt;{{Cite web|url=https://www.nature.com/articles/s41598-017-18305-x|title=|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Other Resources ===&lt;br /&gt;
Dr. Berg with a good explanation of bile salts:&lt;br /&gt;
&lt;br /&gt;
https://youtu.be/wKLiXJqVIY8&lt;br /&gt;
&lt;br /&gt;
A link between polymorphonuclear leukocyteintracellular calcium, plasma insulin, and essentialhypertension&lt;br /&gt;
&lt;br /&gt;
https://bit.ly/2TLu2MP&lt;br /&gt;
&lt;br /&gt;
Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids&lt;br /&gt;
&lt;br /&gt;
https://www.nature.com/articles/s41598-017-18305-x&lt;br /&gt;
&lt;br /&gt;
”The ability to infect and replicate in macrophages is implicated in the pathogenesis of many viruses, such as influenza virus [1], rabies virus [2], and dengue virus [3].”&lt;br /&gt;
&lt;br /&gt;
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774560/&lt;br /&gt;
&lt;br /&gt;
The role of macrophages in influenza A virus infection&lt;br /&gt;
&lt;br /&gt;
https://www.futuremedicine.com/doi/pdf/10.2217/fvl.14.65&lt;br /&gt;
&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=File:Bile_Salt.png&amp;diff=52587</id>
		<title>File:Bile Salt.png</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=File:Bile_Salt.png&amp;diff=52587"/>
		<updated>2019-03-22T19:07:10Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;A bile acid surrounds a fat droplet and allows for it to be absorbed by the body.&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Neuroinflammation&amp;diff=39053</id>
		<title>Neuroinflammation</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Neuroinflammation&amp;diff=39053"/>
		<updated>2018-09-06T19:50:07Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:Microglia and Astrocyte Dysfunction.png|thumb|Possible mechanism showing the decline of microglia and astrocyte function and structure.]]&lt;br /&gt;
&#039;&#039;&#039;Neuroinflammation&#039;&#039;&#039; takes place when the central nervous system (CNS), which consists of the brain and spinal cord, undergoes an immune response. This may be due to microglial cell activation.[[File:ME-CFS Brain Images.jpg|500px|thumb|right|Top Scans: Control Patient, Bottom Scans: ME/CFS Patient]]&lt;br /&gt;
&lt;br /&gt;
Neuroinflammation is thought to occur when immune cells from the body infiltrate the [[central nervous system]] (CNS), which consists of the brain and spinal cord. Infiltration of these immune cells can occur both when the brain is damaged and when there is infection in the body. &amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Graeber|first=Manuel B.|last2=Li|first2=Wei|last3=Rodriguez|first3=Michael L.|date=2011-12-01|title=Role of microglia in CNS inflammation|url=https://www.ncbi.nlm.nih.gov/pubmed/21889505|journal=FEBS letters|volume=585|issue=23|pages=3798–3805|doi=10.1016/j.febslet.2011.08.033|issn=1873-3468|pmid=21889505}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
Microglia, the primary defense cells for the CNS, activate in response to the immune cells and respond to repair the damage in the brain or fight the infection. &amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=DiSabato|first=Damon J.|last2=Quan|first2=Ning|last3=Godbout|first3=Jonathan P.|date=2016-10|title=Neuroinflammation: the devil is in the details|url=https://www.ncbi.nlm.nih.gov/pubmed/26990767|journal=Journal of Neurochemistry|volume=139 Suppl 2|pages=136–153|doi=10.1111/jnc.13607|issn=1471-4159|pmc=PMC5025335|pmid=26990767}}&amp;lt;/ref&amp;gt; Microglia work to restore damaged tissues by activating T-cells leading to further inflammation. Consistent microglia activation and release of T-cells can lead to the chronic damage that perpetuates neuroinflammation. &amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Diseases Associated with Neuroinflammation==&lt;br /&gt;
Neuroinflammation is a symptom of many diseases and thought to be a part of ME. Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis are illnesses in which the brain experiences decline in structure and function, and also where it shows clear signs of neuroinflammation. Inflammation of the brain is linked to activated microglia, cytokine presence in the brain&amp;lt;ref&amp;gt;{{Cite journal|last=CHEN|first=WEI-WEI|last2=ZHANG|first2=XIA|last3=HUANG|first3=WEN-JUAN|date=2016-4|title=Role of neuroinflammation in neurodegenerative diseases (Review)|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805095/|journal=Molecular Medicine Reports|volume=13|issue=4|pages=3391–3396|doi=10.3892/mmr.2016.4948|issn=1791-2997|pmc=PMC4805095|pmid=26935478}}&amp;lt;/ref&amp;gt;, and changes in the neurochemicals produced by the brain&amp;lt;ref name=&amp;quot;:2&amp;quot;&amp;gt;{{Cite journal|last=Albrecht|first=Daniel S.|last2=Granziera|first2=Cristina|last3=Hooker|first3=Jacob M.|last4=Loggia|first4=Marco L.|date=2016-04-20|title=In Vivo Imaging of Human Neuroinflammation|url=https://www.ncbi.nlm.nih.gov/pubmed/26985861|journal=ACS chemical neuroscience|volume=7|issue=4|pages=470–483|doi=10.1021/acschemneuro.6b00056|issn=1948-7193|pmc=PMC5433433|pmid=26985861}}&amp;lt;/ref&amp;gt;. These effects also occur in ME which is why researchers are searching to more strongly show neuroinflammation in these patients. &lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
&lt;br /&gt;
=== Microglia Activation ===&lt;br /&gt;
The blood brain barrier (BBB), a membrane that separates the brain from the rest of the body, may become compromised in ME patients. If there are cytokines circulating in the bloodstream, they may get into the brain through opened sections of the BBB&amp;lt;ref name=&amp;quot;:3&amp;quot;&amp;gt;{{Cite journal|last=Morris|first=Gerwyn|last2=Maes|first2=Michael|date=2013-12|title=A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/22718491|journal=Metabolic Brain Disease|volume=28|issue=4|pages=523–540|doi=10.1007/s11011-012-9324-8|issn=1573-7365|pmid=22718491}}&amp;lt;/ref&amp;gt;. While this initially starts as a normal brain response so that the brain can get the body back to normal, healthy functioning, this process can be predisposed to dysfunction and activation may be sustained longer than usual.&lt;br /&gt;
&lt;br /&gt;
Microglia are cells that can act as the brain’s primary immune response. If cytokines or immune cells from outside the CNS enter the brain through the BBB, the microglia will respond to the immune threat and attempt to clear the infiltrators out. However, this process increases neuron activation and the release of more cytokines potentially leading to a cycle of neuroinflammation&amp;lt;ref name=&amp;quot;:3&amp;quot; /&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
One study used a radioligand, a tracer that lights up in the presence of a specific molecule, in a positron emission tomography (PET) scanner in search of activated microglia in ME patients’ brains. Activated microglia cells are believed to be correlated to neuroinflammation. Increased radioligand presence in ME subjects’ brains was observed; however, further analysis of these data and replication of their results are needed&amp;lt;ref&amp;gt;{{Cite journal|last=Nakatomi|first=Yasuhito|last2=Mizuno|first2=Kei|last3=Ishii|first3=Akira|last4=Wada|first4=Yasuhiro|last5=Tanaka|first5=Masaaki|last6=Tazawa|first6=Shusaku|last7=Onoe|first7=Kayo|last8=Fukuda|first8=Sanae|last9=Kawabe|first9=Joji|date=2014-6|title=Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹C-(R)-PK11195 PET Study|url=https://www.ncbi.nlm.nih.gov/pubmed/24665088|journal=Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine|volume=55|issue=6|pages=945–950|doi=10.2967/jnumed.113.131045|issn=1535-5667|pmid=24665088}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
===Oxidative and Nitrosative Stress===&lt;br /&gt;
Neuroinflammation may also be related to excess oxygen and nitrogen molecules in tissues.  This can cause oxidative or nitrosative stress (O&amp;amp;NS), leading to tissue damage. The O&amp;amp;NS pathway helps maintain the blood brain barrier, an important membrane keeping the brain protected from harmful substances present in the blood. When the pathway is dysfunctional, the blood-brain barrier becomes less effective at keeping out particles. Breakdown of this barrier could lead to immune cells entering the brain and trigger an immune response, leading to neuroinflammation. Researchers propose a link between the dysfunction of brain tissues in ME/ and the breakdown of the oxidative and nitrosative stress pathway&amp;lt;ref name=&amp;quot;:3&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
=== Activation of cyclical neuroinflammation: A self-perpetuating cycle ===&lt;br /&gt;
When a patient gets an infection, the body attempts to return homeostasis. The immune system has regulatory structures called toll-like receptors (TLRs). High amounts of stress or a previous injury can predispose an individual’s TLRs to be more sensitive, releasing inflammatory molecules more readily in response to an immune stressor&amp;lt;ref&amp;gt;{{Cite journal|last=Gárate|first=Iciar|last2=Garcia-Bueno|first2=Borja|last3=Madrigal|first3=Jose Luis Muñoz|last4=Caso|first4=Javier Rubén|last5=Alou|first5=Luis|last6=Gomez-Lus|first6=Marisa L.|last7=Micó|first7=Juan Antonio|last8=Leza|first8=Juan Carlos|date=2013-01-01|title=Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway|url=https://www.ncbi.nlm.nih.gov/pubmed/22906518|journal=Biological Psychiatry|volume=73|issue=1|pages=32–43|doi=10.1016/j.biopsych.2012.07.005|issn=1873-2402|pmid=22906518}}&amp;lt;/ref&amp;gt;. One of the downstream pathways of TLRs, the oxidative and nitrosative stress pathway (O&amp;amp;NS) can get activated. If this pathway is overstimulated, the body will produce a larger-scale response in an effort to return to normal&amp;lt;ref&amp;gt;{{Cite journal|last=Liu|first=JiaJun|last2=Buisman-Pijlman|first2=Femke|last3=Hutchinson|first3=Mark R.|date=2014|title=Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder|url=https://www.ncbi.nlm.nih.gov/pubmed/25324715|journal=Frontiers in Neuroscience|volume=8|pages=309|doi=10.3389/fnins.2014.00309|issn=1662-4548|pmc=PMC4179746|pmid=25324715}}&amp;lt;/ref&amp;gt;. In this attempt, a chemical called damage-associated molecular patterns (DAMPs) triggers the release of more inflammatory molecules, some of which activate the TLRs&amp;lt;ref&amp;gt;{{Cite journal|last=Morris|first=Gerwyn|last2=Berk|first2=Michael|last3=Walder|first3=Ken|last4=Maes|first4=Michael|date=2015-02-06|title=Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses|url=https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-014-0259-2|journal=BMC Medicine|language=En|volume=13|issue=1|doi=10.1186/s12916-014-0259-2|issn=1741-7015|pmc=PMC4320458|pmid=25856766}}&amp;lt;/ref&amp;gt; (Morris et al., 2015). The process of activation from TLRs to the O&amp;amp;NS pathway to the production of more inflammatory molecules then becom&amp;lt;ref name=&amp;quot;:4&amp;quot;&amp;gt;{{Cite journal|last=Chaudhuri|first=A.|last2=Condon|first2=B. R.|last3=Gow|first3=J. W.|last4=Brennan|first4=D.|last5=Hadley|first5=D. M.|date=2003-02-10|title=Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/12598734|journal=Neuroreport|volume=14|issue=2|pages=225–228|doi=10.1097/01.wnr.0000054960.21656.64|issn=0959-4965|pmid=12598734}}&amp;lt;/ref&amp;gt;es a cycle.&lt;br /&gt;
&lt;br /&gt;
== Possible Neurological Biomarkers of ME ==&lt;br /&gt;
When the brain is going through challenges such as neuroinflammation or neurodegeneration, several chemicals become dysregulated. These changes are able to be recorded using a special function of magnetic resonance (MR) scanners. Because each chemical has a distinct molecular structure, the magnetic field formed by the scanner will bounce off of each chemical in unique ways.  This allows the technician to measure the amounts of these chemicals in the brain.&lt;br /&gt;
&lt;br /&gt;
Several neurochemicals have been studied in relation to ME patients. Myo-inositol is thought to be involved in astrocyte function (Albrecht et al. 2016) and trended to be higher in ME patients compared to controls&amp;lt;ref name=&amp;quot;:5&amp;quot;&amp;gt;{{Cite journal|last=Brooks|first=J. C.|last2=Roberts|first2=N.|last3=Whitehouse|first3=G.|last4=Majeed|first4=T.|date=2000-11|title=Proton magnetic resonance spectroscopy and morphometry of the hippocampus in chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/11144799|journal=The British Journal of Radiology|volume=73|issue=875|pages=1206–1208|doi=10.1259/bjr.73.875.11144799|issn=0007-1285|pmid=11144799}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
N-acetylacetate (NAA) shows neuron density, which has been found in other neurological disorders&amp;lt;ref name=&amp;quot;:2&amp;quot; /&amp;gt; and has been shown to be lower in ME patients&amp;lt;ref name=&amp;quot;:4&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:5&amp;quot; /&amp;gt;, but this was not found in all studies&amp;lt;ref&amp;gt;{{Cite journal|last=Puri|first=B. K.|last2=Counsell|first2=S. J.|last3=Zaman|first3=R.|last4=Main|first4=J.|last5=Collins|first5=A. G.|last6=Hajnal|first6=J. V.|last7=Davey|first7=N. J.|date=2002-9|title=Relative increase in choline in the occipital cortex in chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/12197861|journal=Acta Psychiatrica Scandinavica|volume=106|issue=3|pages=224–226|issn=0001-690X|pmid=12197861}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;:6&amp;quot;&amp;gt;{{Cite journal|last=Tomoda|first=A.|last2=Miike|first2=T.|last3=Yamada|first3=E.|last4=Honda|first4=H.|last5=Moroi|first5=T.|last6=Ogawa|first6=M.|last7=Ohtani|first7=Y.|last8=Morishita|first8=S.|date=2000-1|title=Chronic fatigue syndrome in childhood|url=https://www.ncbi.nlm.nih.gov/pubmed/10761837|journal=Brain &amp;amp; Development|volume=22|issue=1|pages=60–64|issn=0387-7604|pmid=10761837}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Choline is linked to activation of glia, loss of energy and expression of macrophages in the brain&amp;lt;ref name=&amp;quot;:2&amp;quot; /&amp;gt; and has been shown to change compared to controls&amp;lt;ref name=&amp;quot;:4&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:5&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:6&amp;quot; /&amp;gt; &amp;lt;ref&amp;gt;{{Cite journal|last=Puri|first=B. K.|last2=Agour|first2=M.|last3=Gunatilake|first3=K. D. R.|last4=Fernando|first4=K. a. C.|last5=Gurusinghe|first5=A. I.|last6=Treasaden|first6=I. H.|date=2009-11|title=An in vivo proton neurospectroscopy study of cerebral oxidative stress in myalgic encephalomyelitis (chronic fatigue syndrome)|url=https://www.ncbi.nlm.nih.gov/pubmed/19906518|journal=Prostaglandins, Leukotrienes, and Essential Fatty Acids|volume=81|issue=5-6|pages=303–305|doi=10.1016/j.plefa.2009.10.002|issn=1532-2823|pmid=19906518}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Lactate increases when more energy is being expended and has been shown to be higher than controls&amp;lt;ref name=&amp;quot;:7&amp;quot;&amp;gt;{{Cite journal|last=Mathew|first=Sanjay J.|last2=Mao|first2=Xiangling|last3=Keegan|first3=Kathryn A.|last4=Levine|first4=Susan M.|last5=Smith|first5=Eric L. P.|last6=Heier|first6=Linda A.|last7=Otcheretko|first7=Viktor|last8=Coplan|first8=Jeremy D.|last9=Shungu|first9=Dikoma C.|date=2009-4|title=Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T (1)H MRS imaging study|url=https://www.ncbi.nlm.nih.gov/pubmed/18942064|journal=NMR in biomedicine|volume=22|issue=3|pages=251–258|doi=10.1002/nbm.1315|issn=0952-3480|pmid=18942064}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Shungu|first=Dikoma C.|last2=Weiduschat|first2=Nora|last3=Murrough|first3=James W.|last4=Mao|first4=Xiangling|last5=Pillemer|first5=Sarah|last6=Dyke|first6=Jonathan P.|last7=Medow|first7=Marvin S.|last8=Natelson|first8=Benjamin H.|last9=Stewart|first9=Julian M.|date=2012-9|title=Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology|url=https://www.ncbi.nlm.nih.gov/pubmed/22281935|journal=NMR in biomedicine|volume=25|issue=9|pages=1073–1087|doi=10.1002/nbm.2772|issn=1099-1492|pmc=PMC3896084|pmid=22281935}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;:8&amp;quot;&amp;gt;{{Cite journal|last=Natelson|first=Benjamin H.|last2=Vu|first2=Diana|last3=Coplan|first3=Jeremy D.|last4=Mao|first4=Xiangling|last5=Blate|first5=Michelle|last6=Kang|first6=Guoxin|last7=Soto|first7=Eli|last8=Kapusuz|first8=Tolga|last9=Shungu|first9=Dikoma C.|date=2017|title=Elevations of Ventricular Lactate Levels Occur in Both Chronic Fatigue Syndrome and Fibromyalgia|url=https://www.ncbi.nlm.nih.gov/pubmed/29308330|journal=Fatigue: Biomedicine, Health &amp;amp; Behavior|volume=5|issue=1|pages=15–20|doi=10.1080/21641846.2017.1280114|issn=2164-1846|pmc=PMC5754037|pmid=29308330}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;:9&amp;quot;&amp;gt;{{Cite journal|last=Murrough|first=James W.|last2=Mao|first2=Xiangling|last3=Collins|first3=Katherine A.|last4=Kelly|first4=Chris|last5=Andrade|first5=Gizely|last6=Nestadt|first6=Paul|last7=Levine|first7=Susan M.|last8=Mathew|first8=Sanjay J.|last9=Shungu|first9=Dikoma C.|date=2010-7|title=Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder|url=https://www.ncbi.nlm.nih.gov/pubmed/20661876|journal=NMR in biomedicine|volume=23|issue=6|pages=643–650|doi=10.1002/nbm.1512|issn=1099-1492|pmid=20661876}}&amp;lt;/ref&amp;gt;, and significantly differs from lactate levels in people with psychological disorders&amp;lt;ref name=&amp;quot;:7&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:9&amp;quot; /&amp;gt;. Both ME patients and fibromyalgia patients were found to have similar levels of elevated lactate, so more tests would be needed to differentiate the two&amp;lt;ref name=&amp;quot;:8&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
Though contrasts were found between ME people and controls in many of these biomarker studies, researchers are not sure what the changes mean specifically because the metabolites are used in multiple brain processes. Furthermore, the results shown by these papers has not been largely replicated. However, if repeated, these biomarkers could potentially become an objective measure for diagnosing ME.&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2010, Autopsies of four deceased ME patients showed various pathological phenomena in the central and [[peripheral nervous system]]s. &amp;lt;ref&amp;gt;{{Cite web|url=https://www.meassociation.org.uk/2011/01/pathology-of-mecfs-pilot-study-of-four-autopsy-reports/|title=Pathology of ME/CFS: pilot study of four autopsy reports|last=|first=|date=Jan 2011|website=www.meassociation.org.uk|language=en-US|archive-url=|archive-date=|dead-url=|access-date=2018-08-10}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*2014, [[Brains of People With Chronic Fatigue Syndrome Offer Clues About Disorder]]&#039;. NY Times Well article by [[David Tuller]] on the [[brain scans]] of [[ME/CFS]] patient&#039;s researched by [[Stanford ME/CFS Initiative]]. (2014)&amp;lt;ref&amp;gt;{{Cite news|url=http://well.blogs.nytimes.com/2014/11/24/brains-of-people-with-chronic-fatigue-syndrome-offer-clues-about-disorder/?_r=0|title=Brains of People With Chronic Fatigue Syndrome Offer Clues About Disorder|last=Tuller|first=David|date=Nov 24, 2014|work=Well|access-date=2018-08-10|archive-url=|archive-date=|dead-url=|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Talks &amp;amp; interviews==&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=1p6UojKL010 Do you have a hot brain?]&amp;lt;ref&amp;gt;{{Cite web|url=https://www.youtube.com/watch?v=1p6UojKL010|title=Do you have a hot brain?|last=Younger|first=Jarred|date=Apr 25, 2016|website=YouTube|via=Younger Lab|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=_ijlkRwORfM What is neuroinflammation?]&amp;lt;ref&amp;gt;{{Cite web|url=https://www.youtube.com/watch?v=_ijlkRwORfM|title=What is neuroinflammation?|last=Younger|first=Jarred|date=Apr 4, 2016|website=YouTube|via=Younger Lab|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Neuroinflammation Wikipedia]&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
*[[Brain imaging]]&lt;br /&gt;
*[[Jarred Younger]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Body systems]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Neuroinflammation&amp;diff=38767</id>
		<title>Neuroinflammation</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Neuroinflammation&amp;diff=38767"/>
		<updated>2018-08-30T16:29:14Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:edit&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:ME-CFS Brain Images.jpg|500px|thumb|right|Top Scans: Control Patient, Bottom Scans: ME/CFS Patient]]&lt;br /&gt;
&lt;br /&gt;
A concrete definition for [[neuroinflammation]] is not fully agreed on in the scientific world yet, but it is thought to follow similar patterns that inflammation in the rest of the body follows. [[Inflammation]], in general, occurs when a pathogen, or something foreign to the body, gets into the body. The body detects the toxin with immune cells which then signal other immune cells to help eliminate the pathogen. The response and build-up of these immune cells is what is referred to as inflammation. The [[central nervous system]] ([[brain]] and [[spinal cord]]; CNS) are believed to do the same sort action with different types of cells. One of the main immune cells in the CNS is [[microglia]], a type of brain cell that, when activated, signals other immune cells to help the brain fight diseases. This action is similar to how the body fights infection. Therefore, neuroinflammation is described as a combination of microglial activation and its response.&amp;lt;ref&amp;gt;Graeber, M. B., Li, W., &amp;amp; Rodriguez, M. L. (2011). Role of microglia in CNS inflammation. FEBS letters, 585(23), 3798-3805.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Evidence==&lt;br /&gt;
===Immune and Brain Interaction===&lt;br /&gt;
Research has shown that the brain and the immune system communicate through the [[vagus nerve]]&amp;lt;ref name=&amp;quot;Goehler et al. 1997&amp;quot;&amp;gt;Goehler, L. E., Relton, J. K., Dripps, D., Kiechle, R., Tartaglia, N., Maier, S. F., &amp;amp; Watkins, L. R. (1997). Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain research bulletin, 43(3), 357-364&amp;lt;/ref&amp;gt;. , a highly branched nerve that controls several systems of the body including sensory information to and from the heart, lungs and stomach, muscle movement including speech, homeostatic control of the heart, lungs and stomach, in addition to its effects in the immune system&amp;lt;ref&amp;gt;{{Cite news|url=https://www.medicalnewstoday.com/articles/318128.php|title=Vagus nerve: Function, stimulation, and further research|last=Sampson|first=Stacy|date=Jun 28, 2017|work=Medical News Today|access-date=2018-08-10|archive-url=|archive-date=|dead-url=|language=en}}&amp;lt;/ref&amp;gt;. When the body is infected by a foreign substance such as bacteria or a virus, the blood has sensors called [[macrophage]]s floating around to detect the contaminate. The macrophages release the protein [[interleukin 1]] beta (IL-1B) to start signaling the brain that there is a contagion present. This protein attaches to nearby vagus nerve protein receptors and upon connection, the vagus nerve alerts the brain to begin fighting off the [[bacteria]] or [[virus]] at this location. Activation of the vagus nerve in this manner causes the body to experience typical behaviors of a sick person such as sensitivity to pain stimuli, decreased appetite, and fever, all of which are regulated by the nerve&amp;lt;ref name=&amp;quot;Goehler et al. 1997&amp;quot;&amp;gt;Goehler, L. E., Relton, J. K., Dripps, D., Kiechle, R., Tartaglia, N., Maier, S. F., &amp;amp; Watkins, L. R. (1997). Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain research bulletin, 43(3), 357-364&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Signaling along the vagus nerve pathway does not occur in isolation; when the nerve is firing in the brain, other neuronal cells also start to function in coordination. [[Glia]], a different type of brain cell that lie adjacent to nerves and [[neurons]] in the brain, also becomes activated. The problem with activating the glial is that it can also trigger more cells to start functioning&amp;lt;ref&amp;gt;Ren, K., and Dubner, R. (2008). Neuron-glia crosstalk gets serious: role in pain [[hypersensitivity]]. Curr. Opin. Anaesthesiol. 21, 570–579.&amp;lt;/ref&amp;gt;. Continued activation of this pathway could cause dysfunction leading to symptoms present in [[chronic fatigue syndrome]], including neuroinflammation&amp;lt;ref&amp;gt;VanElzakker, M. B. (2013). Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Medical hypotheses, 81(3), 414-423.&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
===Oxidative and Nitrosative Stress===&lt;br /&gt;
One possible for what may cause the inflamed cells in the brain follows a oxygen and [[nitrogen molecules]]. An overabundance of oxygen and nitrogen molecules in tissues can cause [[oxidative]] and [[nitrosative stress]]. The build-up causes negative chemical reaction between the tissues and the molecules leading to tissue damage. This relates to neuroinflammation because researchers propose a link between the dysfunction of brain tissues in ME/CFS and the breakdown of the oxidative and nitrosative stress pathway. This pathway helps maintain the [[blood-brain barrier]], an important [[membrane]] keeping the brain protected from harmful substances present in the blood. When the pathway is dysfunctional, the blood-brain barrier becomes less effective at keeping out particles. This loss of efficacy could lead to [[immune cells]] entering the brain and beginning an immune response that leads to inflammation (e.g. neuroinflammation). &amp;lt;ref&amp;gt;Morris, G., and Maes, M. (2014). Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Current neuropharmacology, 12(2), 168-185.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2010, Autopsies of four deceased ME patients showed various pathological phenomena in the central and [[peripheral nervous system]]s. &amp;lt;ref&amp;gt;{{Cite web|url=https://www.meassociation.org.uk/2011/01/pathology-of-mecfs-pilot-study-of-four-autopsy-reports/|title=Pathology of ME/CFS: pilot study of four autopsy reports|last=|first=|date=Jan 2011|website=www.meassociation.org.uk|language=en-US|archive-url=|archive-date=|dead-url=|access-date=2018-08-10}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*2014, [[Brains of People With Chronic Fatigue Syndrome Offer Clues About Disorder]]&#039;. NY Times Well article by [[David Tuller]] on the [[brain scans]] of [[ME/CFS]] patient&#039;s researched by [[Stanford ME/CFS Initiative]]. (2014)&amp;lt;ref&amp;gt;{{Cite news|url=http://well.blogs.nytimes.com/2014/11/24/brains-of-people-with-chronic-fatigue-syndrome-offer-clues-about-disorder/?_r=0|title=Brains of People With Chronic Fatigue Syndrome Offer Clues About Disorder|last=Tuller|first=David|date=Nov 24, 2014|work=Well|access-date=2018-08-10|archive-url=|archive-date=|dead-url=|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Talks &amp;amp; interviews==&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=1p6UojKL010 Do you have a hot brain?]&amp;lt;ref&amp;gt;{{Cite web|url=https://www.youtube.com/watch?v=1p6UojKL010|title=Do you have a hot brain?|last=Younger|first=Jarred|date=Apr 25, 2016|website=YouTube|via=Younger Lab|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=_ijlkRwORfM What is neuroinflammation?]&amp;lt;ref&amp;gt;{{Cite web|url=https://www.youtube.com/watch?v=_ijlkRwORfM|title=What is neuroinflammation?|last=Younger|first=Jarred|date=Apr 4, 2016|website=YouTube|via=Younger Lab|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Neuroinflammation Wikipedia]&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
*[[Brain imaging]]&lt;br /&gt;
*[[Jarred Younger]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Body systems]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Neuroinflammation&amp;diff=38766</id>
		<title>Neuroinflammation</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Neuroinflammation&amp;diff=38766"/>
		<updated>2018-08-30T16:28:27Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:edit&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;aa[[File:ME-CFS Brain Images.jpg|500px|thumb|right|Top Scans: Control Patient, Bottom Scans: ME/CFS Patient]]&lt;br /&gt;
&lt;br /&gt;
A concrete definition for [[neuroinflammation]] is not fully agreed on in the scientific world yet, but it is thought to follow similar patterns that inflammation in the rest of the body follows. [[Inflammation]], in general, occurs when a pathogen, or something foreign to the body, gets into the body. The body detects the toxin with immune cells which then signal other immune cells to help eliminate the pathogen. The response and build-up of these immune cells is what is referred to as inflammation. The [[central nervous system]] ([[brain]] and [[spinal cord]]; CNS) are believed to do the same sort action with different types of cells. One of the main immune cells in the CNS is [[microglia]], a type of brain cell that, when activated, signals other immune cells to help the brain fight diseases. This action is similar to how the body fights infection. Therefore, neuroinflammation is described as a combination of microglial activation and its response.&amp;lt;ref&amp;gt;Graeber, M. B., Li, W., &amp;amp; Rodriguez, M. L. (2011). Role of microglia in CNS inflammation. FEBS letters, 585(23), 3798-3805.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Evidence==&lt;br /&gt;
===Immune and Brain Interaction===&lt;br /&gt;
Research has shown that the brain and the immune system communicate through the [[vagus nerve]]&amp;lt;ref name=&amp;quot;Goehler et al. 1997&amp;quot;&amp;gt;Goehler, L. E., Relton, J. K., Dripps, D., Kiechle, R., Tartaglia, N., Maier, S. F., &amp;amp; Watkins, L. R. (1997). Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain research bulletin, 43(3), 357-364&amp;lt;/ref&amp;gt;. , a highly branched nerve that controls several systems of the body including sensory information to and from the heart, lungs and stomach, muscle movement including speech, homeostatic control of the heart, lungs and stomach, in addition to its effects in the immune system&amp;lt;ref&amp;gt;{{Cite news|url=https://www.medicalnewstoday.com/articles/318128.php|title=Vagus nerve: Function, stimulation, and further research|last=Sampson|first=Stacy|date=Jun 28, 2017|work=Medical News Today|access-date=2018-08-10|archive-url=|archive-date=|dead-url=|language=en}}&amp;lt;/ref&amp;gt;. When the body is infected by a foreign substance such as bacteria or a virus, the blood has sensors called [[macrophage]]s floating around to detect the contaminate. The macrophages release the protein [[interleukin 1]] beta (IL-1B) to start signaling the brain that there is a contagion present. This protein attaches to nearby vagus nerve protein receptors and upon connection, the vagus nerve alerts the brain to begin fighting off the [[bacteria]] or [[virus]] at this location. Activation of the vagus nerve in this manner causes the body to experience typical behaviors of a sick person such as sensitivity to pain stimuli, decreased appetite, and fever, all of which are regulated by the nerve&amp;lt;ref name=&amp;quot;Goehler et al. 1997&amp;quot;&amp;gt;Goehler, L. E., Relton, J. K., Dripps, D., Kiechle, R., Tartaglia, N., Maier, S. F., &amp;amp; Watkins, L. R. (1997). Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain research bulletin, 43(3), 357-364&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Signaling along the vagus nerve pathway does not occur in isolation; when the nerve is firing in the brain, other neuronal cells also start to function in coordination. [[Glia]], a different type of brain cell that lie adjacent to nerves and [[neurons]] in the brain, also becomes activated. The problem with activating the glial is that it can also trigger more cells to start functioning&amp;lt;ref&amp;gt;Ren, K., and Dubner, R. (2008). Neuron-glia crosstalk gets serious: role in pain [[hypersensitivity]]. Curr. Opin. Anaesthesiol. 21, 570–579.&amp;lt;/ref&amp;gt;. Continued activation of this pathway could cause dysfunction leading to symptoms present in [[chronic fatigue syndrome]], including neuroinflammation&amp;lt;ref&amp;gt;VanElzakker, M. B. (2013). Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Medical hypotheses, 81(3), 414-423.&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
===Oxidative and Nitrosative Stress===&lt;br /&gt;
One possible for what may cause the inflamed cells in the brain follows a oxygen and [[nitrogen molecules]]. An overabundance of oxygen and nitrogen molecules in tissues can cause [[oxidative]] and [[nitrosative stress]]. The build-up causes negative chemical reaction between the tissues and the molecules leading to tissue damage. This relates to neuroinflammation because researchers propose a link between the dysfunction of brain tissues in ME/CFS and the breakdown of the oxidative and nitrosative stress pathway. This pathway helps maintain the [[blood-brain barrier]], an important [[membrane]] keeping the brain protected from harmful substances present in the blood. When the pathway is dysfunctional, the blood-brain barrier becomes less effective at keeping out particles. This loss of efficacy could lead to [[immune cells]] entering the brain and beginning an immune response that leads to inflammation (e.g. neuroinflammation). &amp;lt;ref&amp;gt;Morris, G., and Maes, M. (2014). Oxidative and nitrosative stress and immune-inflammatory pathways in patients with myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS). Current neuropharmacology, 12(2), 168-185.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2010, Autopsies of four deceased ME patients showed various pathological phenomena in the central and [[peripheral nervous system]]s. &amp;lt;ref&amp;gt;{{Cite web|url=https://www.meassociation.org.uk/2011/01/pathology-of-mecfs-pilot-study-of-four-autopsy-reports/|title=Pathology of ME/CFS: pilot study of four autopsy reports|last=|first=|date=Jan 2011|website=www.meassociation.org.uk|language=en-US|archive-url=|archive-date=|dead-url=|access-date=2018-08-10}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*2014, [[Brains of People With Chronic Fatigue Syndrome Offer Clues About Disorder]]&#039;. NY Times Well article by [[David Tuller]] on the [[brain scans]] of [[ME/CFS]] patient&#039;s researched by [[Stanford ME/CFS Initiative]]. (2014)&amp;lt;ref&amp;gt;{{Cite news|url=http://well.blogs.nytimes.com/2014/11/24/brains-of-people-with-chronic-fatigue-syndrome-offer-clues-about-disorder/?_r=0|title=Brains of People With Chronic Fatigue Syndrome Offer Clues About Disorder|last=Tuller|first=David|date=Nov 24, 2014|work=Well|access-date=2018-08-10|archive-url=|archive-date=|dead-url=|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Talks &amp;amp; interviews==&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=1p6UojKL010 Do you have a hot brain?]&amp;lt;ref&amp;gt;{{Cite web|url=https://www.youtube.com/watch?v=1p6UojKL010|title=Do you have a hot brain?|last=Younger|first=Jarred|date=Apr 25, 2016|website=YouTube|via=Younger Lab|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=_ijlkRwORfM What is neuroinflammation?]&amp;lt;ref&amp;gt;{{Cite web|url=https://www.youtube.com/watch?v=_ijlkRwORfM|title=What is neuroinflammation?|last=Younger|first=Jarred|date=Apr 4, 2016|website=YouTube|via=Younger Lab|archive-url=|archive-date=|dead-url=|access-date=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Neuroinflammation Wikipedia]&lt;br /&gt;
&lt;br /&gt;
== See also ==&lt;br /&gt;
*[[Brain imaging]]&lt;br /&gt;
*[[Jarred Younger]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Body systems]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=File:Brain.png&amp;diff=38764</id>
		<title>File:Brain.png</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=File:Brain.png&amp;diff=38764"/>
		<updated>2018-08-30T16:19:18Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Brain matter&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37619</id>
		<title>Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37619"/>
		<updated>2018-08-15T17:17:02Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* The Energy Envelope Theory */ /&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pacing==&lt;br /&gt;
Pacing is one way for those diagnosed with myalgic encephalomyelitis (ME) to balance activity and rest and may even reduce symptom severity and the frequency of relapses&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite book|title=Pacing for People with M.E.|last=|first=|publisher=Action for M.E.|year=2013|isbn=|location=Bristol|pages=}}&amp;lt;/ref&amp;gt;. Day-to-day energy levels for those with ME are often unpredictable; however, pacing allows patients to assess their perceived energy levels on a daily basis (or in smaller time increments, as needed) and use that level to gauge their energy expenditure for the day. Pacing encourages [[ME/CFS|ME]] patients to accept their daily energy limitations and not exceed or fight them.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; Pacing is based on four main principles, and when practiced it can help to &amp;quot;support the body&#039;s natural recovery process&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&amp;quot; The four goals to pacing are activity, rest/relaxation, establishing a baseline, and increasing activity as you are able. &lt;br /&gt;
&lt;br /&gt;
Activity: Every individual has his or her own definition of what it means to be active and therefore, for some &amp;quot;being active&amp;quot; can vary from taking a shower to talking on the phone or even watching a movie. However, when practicing pacing one should consider activity anything that requires mental or physical energy. &lt;br /&gt;
&lt;br /&gt;
Rest: Each person must also investigate and find out what it means to for them to rest. Rest should mean that both the body and mind are relaxed. For some, this might mean sleep and for others just laying quietly. &lt;br /&gt;
&lt;br /&gt;
Establishing a sustainable baseline: A baseline is a level of activity that can be sustained whether you are having a &amp;quot;good&amp;quot; or a &amp;quot;bad&amp;quot; day. &lt;br /&gt;
&lt;br /&gt;
Increasing activity as you are able: Setting a routine and prioritizing tasks is one way to steadily work up from a baseline. However, it has been suggested that one should avoid pushing his or herself past &amp;quot;safe stores&amp;quot; of energy to avoid woresning of symptoms &amp;lt;ref&amp;gt;{{Cite news|url=https://phoenixrising.me/living-i-the-basics/energy-envelope-in-chronic-fatigue-syndrome-by-cort-johnson|title=Living|work=Phoenix Rising|access-date=2018-08-15|language=en-US}}&amp;lt;/ref&amp;gt;.  &lt;br /&gt;
&lt;br /&gt;
==The Energy Envelope Theory==&lt;br /&gt;
The &#039;&#039;&#039;Energy Envelope Theory&#039;&#039;&#039; is the idea that those with ME should not expend more energy than they perceive that they have available. Professionals might take the concept further by recommending that those with [[ME/CFS|ME]] do less than their perceived energy would allow, in order to have energy left over for recovery.&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Under the Energy Envelope Theory, treatment programs that recommend a steady increase in daily activity are discouraged because the person with [[ME/CFS|ME]] may exceed the amount of energy available for that day, thereby initiating [[post-exertional malaise]] or an increase in symptoms. Those that stay within their daily &amp;quot;envelope&amp;quot; of energy, have been observed to have fewer symptoms or even recover to a higher functioning level.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=O’connor|first=Kelly|last2=Sunnquist|first2=Madison|last3=Nicholson|first3=Laura|last4=Jason|first4=Leonard A|last5=Newton|first5=Julia L|last6=Strand|first6=Elin B|date=2017-12-12|title=Energy envelope maintenance among patients with myalgic encephalomyelitis and chronic fatigue syndrome: Implications of limited energy reserves|url=https://doi.org/10.1177/1742395317746470|journal=Chronic Illness|language=en|pages=1742395317746470|doi=10.1177/1742395317746470|issn=1742-3953|pmc=PMC5750135|pmid=29231037}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The concept of staying within one&#039;s &amp;quot;energy envelope&amp;quot; is a similar technique as the [[spoon theory]].&lt;br /&gt;
&lt;br /&gt;
==Patient experiences with the Envelope Theory==&lt;br /&gt;
*The [[Just ME]] blogger, Sally Burch, has written about self-pacing and [http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html the energy envelope] in a post called &#039;&#039;&amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot;&#039;&#039;.&amp;lt;ref&amp;gt;[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up not Boom &amp;amp; Bust]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Bruce Campbell, PhD, has included the Envelope Theory in chapter 7 of his manual, &#039;&#039;Recovery from Chronic Fatigue Syndrome: One Person&#039;s Story&#039;&#039;&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
*http://www.cfidsselfhelp.org/library/how-i-use-pacing-manage-cfs &lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2013, Energy Conservation/[[Energy Envelope Theory|Envelope Theory]] Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596172/ (Full Text)]&lt;br /&gt;
*2008, The [[Energy Envelope Theory]] and [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/5276419_The_Energy_Envelope_Theory_and_myalgic_encephalomyelitischronic_fatigue_syndrome (Full text)]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot; - Sally Burch]&lt;br /&gt;
*[http://solvecfs.org/wp-content/uploads/2013/06/080505.pdf Solve ME/CFS Initiative - Managing Your Energy Envelope by Bruce Campbell (pdf)]&lt;br /&gt;
*[http://www.healthrising.org/blog/2013/05/17/coping-works-in-chronic-fatigue-syndrome-except-when-it-doesnt-study-suggests-large-group-gets-no-help/ Health Rising - Coping vs Energy Envelope in CFS]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Post-exertional malaise]]&lt;br /&gt;
*[[Pacing]]&lt;br /&gt;
*[[Pacing with a heart rate monitor]]&lt;br /&gt;
*[[Bed rest]]&lt;br /&gt;
*[[Spoon theory]]&lt;br /&gt;
*[[Graded exercise therapy]]&lt;br /&gt;
*[[Activity management based on 2-day cardiopulmonary exercise testing results]]&lt;br /&gt;
*[[Mindfulness]]&lt;br /&gt;
*[[Meditation]]&lt;br /&gt;
*[[Coping strategies]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason             | first1 = Leonard A.             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Muldowney         | first2 = Kathleen               | authorlink2 = &lt;br /&gt;
| last3   = Torres-Harding    | first3 = Susan                  | authorlink3 = Susan Torres-Harding&lt;br /&gt;
| title   = The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome&lt;br /&gt;
| journal = American Association of Occupational Health Nurses | volume = 56 | issue = 5 | page = 189-95&lt;br /&gt;
| date    = 2008&lt;br /&gt;
| doi     = 10.3928/08910162-20080501-06&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason          | first1 = LA          | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Brown          | first2 = M           | authorlink2 = Molly Brown&lt;br /&gt;
| last3   = Brown          | first3 = A           | authorlink3 = Abigail Brown&lt;br /&gt;
| last4   = Evans          | first4 = M           | authorlink4 = Meredyth Evans&lt;br /&gt;
| last5   = Flores         | first5 = S           | authorlink5 = &lt;br /&gt;
| last6   = Grant-Holler   | first6 = E           | authorlink6 = &lt;br /&gt;
| last7   = Sunnquist      | first7 = M           | authorlink7 = Madison Sunnquist&lt;br /&gt;
| title   = Energy conservation/envelope theory interventions&lt;br /&gt;
| journal = Fatigue: Biomedicine, Health &amp;amp; Behavior | volume = 1 | issue = 1-2 | page = 27-42&lt;br /&gt;
| date    = 2013&lt;br /&gt;
| doi     = 10.1080/21641846.2012.733602&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Management strategies]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37616</id>
		<title>Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37616"/>
		<updated>2018-08-15T16:47:30Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* The Energy Envelope Theory */ /&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pacing==&lt;br /&gt;
Pacing is one way for those diagnosed with myalgic encephalomyelitis (ME) to balance activity and rest and may even reduce symptom severity and the frequency of relapses&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite book|title=Pacing for People with M.E.|last=|first=|publisher=Action for M.E.|year=2013|isbn=|location=Bristol|pages=}}&amp;lt;/ref&amp;gt;. Day-to-day energy levels for those with ME are often unpredictable; however, pacing allows patients to assess their perceived energy levels on a daily basis (or in smaller time increments, as needed) and use that level to gauge their energy expenditure for the day. Pacing encourages [[ME/CFS|ME]] patients to accept their daily energy limitations and not exceed or fight them.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; Pacing is based on four main principles, and when practiced it can help to &amp;quot;support the body&#039;s natural recovery process&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&amp;quot; The four goals to pacing are activity, rest/relaxation, establishing a baseline, and increasing activity as you are able. &lt;br /&gt;
&lt;br /&gt;
Activity: Every individual has his or her own definition of what it means to be active and therefore, for some &amp;quot;being active&amp;quot; can vary from taking a shower to talking on the phone or even watching a movie. However, when practicing pacing one should consider activity anything that requires mental or physical energy. &lt;br /&gt;
&lt;br /&gt;
Rest: Each person must also investigate and find out what it means to for them to rest. Rest should mean that both the body and mind are relaxed. For some, this might mean sleep and for others just laying quietly. &lt;br /&gt;
&lt;br /&gt;
Establishing a sustainable baseline: A baseline is a level of activity that can be sustained whether you are having a &amp;quot;good&amp;quot; or a &amp;quot;bad&amp;quot; day. &lt;br /&gt;
&lt;br /&gt;
==The Energy Envelope Theory==&lt;br /&gt;
The &#039;&#039;&#039;Energy Envelope Theory&#039;&#039;&#039; is the idea that those with ME should not expend more energy than they perceive that they have available. The Energy Envelope Theory might take the concept further by recommending that people with [[ME/CFS|ME]] do less than their perceived energy would allow in order to have energy left over for recovery.&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Under the Energy Envelope Theory, treatment programs that recommend a steady increase in daily activity are discouraged because the person with [[ME/CFS|ME]] may exceed the amount of energy available for that day, thereby initiating [[post-exertional malaise]] or an increase in symptoms. Those that stay within their daily &amp;quot;envelope&amp;quot; of energy, not only have fewer symptoms but often recover to a higher functioning level than those who don&#039;t.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The concept of staying within one&#039;s &amp;quot;energy envelope&amp;quot; is a similar technique to the [[spoon theory]].&lt;br /&gt;
&lt;br /&gt;
==Patient experiences with the Envelope Theory==&lt;br /&gt;
*The [[Just ME]] blogger, Sally Burch, has written about self-pacing and [http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html the energy envelope] in a post called &#039;&#039;&amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot;&#039;&#039;.&amp;lt;ref&amp;gt;[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up not Boom &amp;amp; Bust]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Bruce Campbell, PhD, has included the Envelope Theory in chapter 7 of his manual, &#039;&#039;Recovery from Chronic Fatigue Syndrome: One Person&#039;s Story&#039;&#039;&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2013, Energy Conservation/[[Energy Envelope Theory|Envelope Theory]] Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596172/ (Full Text)]&lt;br /&gt;
*2008, The [[Energy Envelope Theory]] and [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/5276419_The_Energy_Envelope_Theory_and_myalgic_encephalomyelitischronic_fatigue_syndrome (Full text)]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot; - Sally Burch]&lt;br /&gt;
*[http://solvecfs.org/wp-content/uploads/2013/06/080505.pdf Solve ME/CFS Initiative - Managing Your Energy Envelope by Bruce Campbell (pdf)]&lt;br /&gt;
*[http://www.healthrising.org/blog/2013/05/17/coping-works-in-chronic-fatigue-syndrome-except-when-it-doesnt-study-suggests-large-group-gets-no-help/ Health Rising - Coping vs Energy Envelope in CFS]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Post-exertional malaise]]&lt;br /&gt;
*[[Pacing]]&lt;br /&gt;
*[[Pacing with a heart rate monitor]]&lt;br /&gt;
*[[Bed rest]]&lt;br /&gt;
*[[Spoon theory]]&lt;br /&gt;
*[[Graded exercise therapy]]&lt;br /&gt;
*[[Activity management based on 2-day cardiopulmonary exercise testing results]]&lt;br /&gt;
*[[Mindfulness]]&lt;br /&gt;
*[[Meditation]]&lt;br /&gt;
*[[Coping strategies]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason             | first1 = Leonard A.             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Muldowney         | first2 = Kathleen               | authorlink2 = &lt;br /&gt;
| last3   = Torres-Harding    | first3 = Susan                  | authorlink3 = Susan Torres-Harding&lt;br /&gt;
| title   = The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome&lt;br /&gt;
| journal = American Association of Occupational Health Nurses | volume = 56 | issue = 5 | page = 189-95&lt;br /&gt;
| date    = 2008&lt;br /&gt;
| doi     = 10.3928/08910162-20080501-06&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason          | first1 = LA          | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Brown          | first2 = M           | authorlink2 = Molly Brown&lt;br /&gt;
| last3   = Brown          | first3 = A           | authorlink3 = Abigail Brown&lt;br /&gt;
| last4   = Evans          | first4 = M           | authorlink4 = Meredyth Evans&lt;br /&gt;
| last5   = Flores         | first5 = S           | authorlink5 = &lt;br /&gt;
| last6   = Grant-Holler   | first6 = E           | authorlink6 = &lt;br /&gt;
| last7   = Sunnquist      | first7 = M           | authorlink7 = Madison Sunnquist&lt;br /&gt;
| title   = Energy conservation/envelope theory interventions&lt;br /&gt;
| journal = Fatigue: Biomedicine, Health &amp;amp; Behavior | volume = 1 | issue = 1-2 | page = 27-42&lt;br /&gt;
| date    = 2013&lt;br /&gt;
| doi     = 10.1080/21641846.2012.733602&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Management strategies]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Talk:Energy_Envelope_Theory&amp;diff=37613</id>
		<title>Talk:Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Talk:Energy_Envelope_Theory&amp;diff=37613"/>
		<updated>2018-08-15T16:39:33Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:Juliajt moved page MEpedia talk:Pacing to Talk:Pace&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=Capitalisation?=&lt;br /&gt;
&lt;br /&gt;
I think this page should be called [[Energy envelope theory]] (without the two later words being capitalised) to match with the rest of the site, but I&#039;m not sure what the rename procedure is around here so hopefully someone sees this in the avalanche of Recent changes! [[User:Jeshyr|Jeshyr]] ([[User talk:Jeshyr|talk]])&lt;br /&gt;
&lt;br /&gt;
:Dr. Leonard Jason coined the term, Energy Envelope Theory, and he always capitalizes all three words. I assume that doing so brands it, making it less likely to be adulterated. [[User:Kmdenmark|Karen]] 8:13 EST 22 May 2018&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37611</id>
		<title>Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37611"/>
		<updated>2018-08-15T16:39:33Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:Juliajt moved page MEpedia:Pacing to Pace&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pacing==&lt;br /&gt;
Pacing is one way for those diagnosed with myalgic encephalomyelitis (ME) to balance activity and rest and may even reduce symptom severity and the frequency of relapses&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite book|title=Pacing for People with M.E.|last=|first=|publisher=Action for M.E.|year=2013|isbn=|location=Bristol|pages=}}&amp;lt;/ref&amp;gt;. Day-to-day energy levels for those with ME are often unpredictable; however, pacing allows patients to assess their perceived energy levels on a daily basis (or in smaller time increments, as needed) and use that level to gauge their energy expenditure for the day. Pacing encourages [[ME/CFS|ME]] patients to accept their daily energy limitations and not exceed or fight them.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; Pacing is based on four main principles, and when practiced it can help to &amp;quot;support the body&#039;s natural recovery process&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&amp;quot; The four goals to pacing are activity, rest/relaxation, establishing a baseline, and increasing activity as you are able. &lt;br /&gt;
&lt;br /&gt;
Activity: Every individual has his or her own definition of what it means to be active and therefore, for some &amp;quot;being active&amp;quot; can vary from taking a shower to talking on the phone or even watching a movie. However, when practicing pacing one should consider activity anything that requires mental or physical energy. &lt;br /&gt;
&lt;br /&gt;
Rest: Each person must also investigate and find out what it means to for them to rest. Rest should mean that both the body and mind are relaxed. For some, this might mean sleep and for others just laying quietly. &lt;br /&gt;
&lt;br /&gt;
Establishing a sustainable baseline: A baseline is a level of activity that can be sustained whether you are having a &amp;quot;good&amp;quot; or a &amp;quot;bad&amp;quot; day. &lt;br /&gt;
&lt;br /&gt;
==The Energy Envelope Theory==&lt;br /&gt;
The &#039;&#039;&#039;Energy Envelope Theory&#039;&#039;&#039; Some practitioners of the Energy Envelope Theory take the concept further by recommending that people with [[ME/CFS]] do less than their perceived energy would allow in order to have energy left over for recovery.&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Under the Energy Envelope Theory, treatment programs that recommend a steady increase in daily activity are discouraged because the person with [[ME/CFS]] may exceed the amount of energy available for that day, thereby initiating [[post-exertional malaise]] or an increase in symptoms. Those that stay within their daily &amp;quot;envelope&amp;quot; of energy, not only have fewer symptoms but often recover to a higher functioning level than those who don&#039;t.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The concept of staying within one&#039;s &amp;quot;energy envelope&amp;quot; is a similar [[pacing]] technique to the [[spoon theory]].&lt;br /&gt;
&lt;br /&gt;
==Patient experiences with the Envelope Theory==&lt;br /&gt;
*The [[Just ME]] blogger, Sally Burch, has written about self-pacing and [http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html the energy envelope] in a post called &#039;&#039;&amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot;&#039;&#039;.&amp;lt;ref&amp;gt;[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up not Boom &amp;amp; Bust]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Bruce Campbell, PhD, has included the Envelope Theory in chapter 7 of his manual, &#039;&#039;Recovery from Chronic Fatigue Syndrome: One Person&#039;s Story&#039;&#039;&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2013, Energy Conservation/[[Energy Envelope Theory|Envelope Theory]] Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596172/ (Full Text)]&lt;br /&gt;
*2008, The [[Energy Envelope Theory]] and [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/5276419_The_Energy_Envelope_Theory_and_myalgic_encephalomyelitischronic_fatigue_syndrome (Full text)]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot; - Sally Burch]&lt;br /&gt;
*[http://solvecfs.org/wp-content/uploads/2013/06/080505.pdf Solve ME/CFS Initiative - Managing Your Energy Envelope by Bruce Campbell (pdf)]&lt;br /&gt;
*[http://www.healthrising.org/blog/2013/05/17/coping-works-in-chronic-fatigue-syndrome-except-when-it-doesnt-study-suggests-large-group-gets-no-help/ Health Rising - Coping vs Energy Envelope in CFS]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Post-exertional malaise]]&lt;br /&gt;
*[[Pacing]]&lt;br /&gt;
*[[Pacing with a heart rate monitor]]&lt;br /&gt;
*[[Bed rest]]&lt;br /&gt;
*[[Spoon theory]]&lt;br /&gt;
*[[Graded exercise therapy]]&lt;br /&gt;
*[[Activity management based on 2-day cardiopulmonary exercise testing results]]&lt;br /&gt;
*[[Mindfulness]]&lt;br /&gt;
*[[Meditation]]&lt;br /&gt;
*[[Coping strategies]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason             | first1 = Leonard A.             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Muldowney         | first2 = Kathleen               | authorlink2 = &lt;br /&gt;
| last3   = Torres-Harding    | first3 = Susan                  | authorlink3 = Susan Torres-Harding&lt;br /&gt;
| title   = The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome&lt;br /&gt;
| journal = American Association of Occupational Health Nurses | volume = 56 | issue = 5 | page = 189-95&lt;br /&gt;
| date    = 2008&lt;br /&gt;
| doi     = 10.3928/08910162-20080501-06&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason          | first1 = LA          | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Brown          | first2 = M           | authorlink2 = Molly Brown&lt;br /&gt;
| last3   = Brown          | first3 = A           | authorlink3 = Abigail Brown&lt;br /&gt;
| last4   = Evans          | first4 = M           | authorlink4 = Meredyth Evans&lt;br /&gt;
| last5   = Flores         | first5 = S           | authorlink5 = &lt;br /&gt;
| last6   = Grant-Holler   | first6 = E           | authorlink6 = &lt;br /&gt;
| last7   = Sunnquist      | first7 = M           | authorlink7 = Madison Sunnquist&lt;br /&gt;
| title   = Energy conservation/envelope theory interventions&lt;br /&gt;
| journal = Fatigue: Biomedicine, Health &amp;amp; Behavior | volume = 1 | issue = 1-2 | page = 27-42&lt;br /&gt;
| date    = 2013&lt;br /&gt;
| doi     = 10.1080/21641846.2012.733602&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Management strategies]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37610</id>
		<title>Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37610"/>
		<updated>2018-08-15T16:34:29Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:xx&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pacing==&lt;br /&gt;
Pacing is one way for those diagnosed with myalgic encephalomyelitis (ME) to balance activity and rest and may even reduce symptom severity and the frequency of relapses&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite book|title=Pacing for People with M.E.|last=|first=|publisher=Action for M.E.|year=2013|isbn=|location=Bristol|pages=}}&amp;lt;/ref&amp;gt;. Day-to-day energy levels for those with ME are often unpredictable; however, pacing allows patients to assess their perceived energy levels on a daily basis (or in smaller time increments, as needed) and use that level to gauge their energy expenditure for the day. Pacing encourages [[ME/CFS|ME]] patients to accept their daily energy limitations and not exceed or fight them.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; Pacing is based on four main principles, and when practiced it can help to &amp;quot;support the body&#039;s natural recovery process&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&amp;quot; The four goals to pacing are activity, rest/relaxation, establishing a baseline, and increasing activity as you are able. &lt;br /&gt;
&lt;br /&gt;
Activity: Every individual has his or her own definition of what it means to be active and therefore, for some &amp;quot;being active&amp;quot; can vary from taking a shower to talking on the phone or even watching a movie. However, when practicing pacing one should consider activity anything that requires mental or physical energy. &lt;br /&gt;
&lt;br /&gt;
Rest: Each person must also investigate and find out what it means to for them to rest. Rest should mean that both the body and mind are relaxed. For some, this might mean sleep and for others just laying quietly. &lt;br /&gt;
&lt;br /&gt;
Establishing a sustainable baseline: A baseline is a level of activity that can be sustained whether you are having a &amp;quot;good&amp;quot; or a &amp;quot;bad&amp;quot; day. &lt;br /&gt;
&lt;br /&gt;
==The Energy Envelope Theory==&lt;br /&gt;
The &#039;&#039;&#039;Energy Envelope Theory&#039;&#039;&#039; Some practitioners of the Energy Envelope Theory take the concept further by recommending that people with [[ME/CFS]] do less than their perceived energy would allow in order to have energy left over for recovery.&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Under the Energy Envelope Theory, treatment programs that recommend a steady increase in daily activity are discouraged because the person with [[ME/CFS]] may exceed the amount of energy available for that day, thereby initiating [[post-exertional malaise]] or an increase in symptoms. Those that stay within their daily &amp;quot;envelope&amp;quot; of energy, not only have fewer symptoms but often recover to a higher functioning level than those who don&#039;t.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The concept of staying within one&#039;s &amp;quot;energy envelope&amp;quot; is a similar [[pacing]] technique to the [[spoon theory]].&lt;br /&gt;
&lt;br /&gt;
==Patient experiences with the Envelope Theory==&lt;br /&gt;
*The [[Just ME]] blogger, Sally Burch, has written about self-pacing and [http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html the energy envelope] in a post called &#039;&#039;&amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot;&#039;&#039;.&amp;lt;ref&amp;gt;[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up not Boom &amp;amp; Bust]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Bruce Campbell, PhD, has included the Envelope Theory in chapter 7 of his manual, &#039;&#039;Recovery from Chronic Fatigue Syndrome: One Person&#039;s Story&#039;&#039;&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2013, Energy Conservation/[[Energy Envelope Theory|Envelope Theory]] Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596172/ (Full Text)]&lt;br /&gt;
*2008, The [[Energy Envelope Theory]] and [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/5276419_The_Energy_Envelope_Theory_and_myalgic_encephalomyelitischronic_fatigue_syndrome (Full text)]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot; - Sally Burch]&lt;br /&gt;
*[http://solvecfs.org/wp-content/uploads/2013/06/080505.pdf Solve ME/CFS Initiative - Managing Your Energy Envelope by Bruce Campbell (pdf)]&lt;br /&gt;
*[http://www.healthrising.org/blog/2013/05/17/coping-works-in-chronic-fatigue-syndrome-except-when-it-doesnt-study-suggests-large-group-gets-no-help/ Health Rising - Coping vs Energy Envelope in CFS]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Post-exertional malaise]]&lt;br /&gt;
*[[Pacing]]&lt;br /&gt;
*[[Pacing with a heart rate monitor]]&lt;br /&gt;
*[[Bed rest]]&lt;br /&gt;
*[[Spoon theory]]&lt;br /&gt;
*[[Graded exercise therapy]]&lt;br /&gt;
*[[Activity management based on 2-day cardiopulmonary exercise testing results]]&lt;br /&gt;
*[[Mindfulness]]&lt;br /&gt;
*[[Meditation]]&lt;br /&gt;
*[[Coping strategies]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason             | first1 = Leonard A.             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Muldowney         | first2 = Kathleen               | authorlink2 = &lt;br /&gt;
| last3   = Torres-Harding    | first3 = Susan                  | authorlink3 = Susan Torres-Harding&lt;br /&gt;
| title   = The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome&lt;br /&gt;
| journal = American Association of Occupational Health Nurses | volume = 56 | issue = 5 | page = 189-95&lt;br /&gt;
| date    = 2008&lt;br /&gt;
| doi     = 10.3928/08910162-20080501-06&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason          | first1 = LA          | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Brown          | first2 = M           | authorlink2 = Molly Brown&lt;br /&gt;
| last3   = Brown          | first3 = A           | authorlink3 = Abigail Brown&lt;br /&gt;
| last4   = Evans          | first4 = M           | authorlink4 = Meredyth Evans&lt;br /&gt;
| last5   = Flores         | first5 = S           | authorlink5 = &lt;br /&gt;
| last6   = Grant-Holler   | first6 = E           | authorlink6 = &lt;br /&gt;
| last7   = Sunnquist      | first7 = M           | authorlink7 = Madison Sunnquist&lt;br /&gt;
| title   = Energy conservation/envelope theory interventions&lt;br /&gt;
| journal = Fatigue: Biomedicine, Health &amp;amp; Behavior | volume = 1 | issue = 1-2 | page = 27-42&lt;br /&gt;
| date    = 2013&lt;br /&gt;
| doi     = 10.1080/21641846.2012.733602&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Management strategies]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Talk:Energy_Envelope_Theory_duplicate&amp;diff=37608</id>
		<title>Talk:Energy Envelope Theory duplicate</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Talk:Energy_Envelope_Theory_duplicate&amp;diff=37608"/>
		<updated>2018-08-15T16:11:04Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:Juliajt moved page Talk:Energy Envelope Theory to MEpedia talk:Pacing: requested&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;#REDIRECT [[MEpedia talk:Pacing]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Talk:Energy_Envelope_Theory&amp;diff=37607</id>
		<title>Talk:Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Talk:Energy_Envelope_Theory&amp;diff=37607"/>
		<updated>2018-08-15T16:11:04Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:Juliajt moved page Talk:Energy Envelope Theory to MEpedia talk:Pacing: requested&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=Capitalisation?=&lt;br /&gt;
&lt;br /&gt;
I think this page should be called [[Energy envelope theory]] (without the two later words being capitalised) to match with the rest of the site, but I&#039;m not sure what the rename procedure is around here so hopefully someone sees this in the avalanche of Recent changes! [[User:Jeshyr|Jeshyr]] ([[User talk:Jeshyr|talk]])&lt;br /&gt;
&lt;br /&gt;
:Dr. Leonard Jason coined the term, Energy Envelope Theory, and he always capitalizes all three words. I assume that doing so brands it, making it less likely to be adulterated. [[User:Kmdenmark|Karen]] 8:13 EST 22 May 2018&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37605</id>
		<title>Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37605"/>
		<updated>2018-08-15T16:11:03Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:Juliajt moved page Energy Envelope Theory to MEpedia:Pacing: requested&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pacing==&lt;br /&gt;
Pacing is one way for those diagnosed with myalgic encephalomyelitis (ME) to balance activity and rest and may even reduce symptom severity and the frequency of relapses&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite book|title=Pacing for People with M.E.|last=|first=|publisher=Action for M.E.|year=2013|isbn=|location=Bristol|pages=}}&amp;lt;/ref&amp;gt;. Day-to-day energy levels for those with ME are often unpredictable; however, pacing allows patients to assess their perceived energy levels on a daily basis (or in smaller time increments, as needed) and use that level to gauge their energy expenditure for the day. Pacing encourages [[ME/CFS|ME]] patients to accept their daily energy limitations and not exceed or fight them.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; Pacing is based on four main principles, and when practiced it can help to &amp;quot;support the body&#039;s natural recovery process&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&amp;quot; The four goals to pacing are activity, rest/relaxation, establishing a baseline, and increasing activity as you are able. &lt;br /&gt;
&lt;br /&gt;
Activity: every individual has his or her own definition of what it means to be active and therefore, &lt;br /&gt;
&lt;br /&gt;
==The Energy Envelope Theory==&lt;br /&gt;
The &#039;&#039;&#039;Energy Envelope Theory&#039;&#039;&#039; Some practitioners of the Energy Envelope Theory take the concept further by recommending that people with [[ME/CFS]] do less than their perceived energy would allow in order to have energy left over for recovery.&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Under the Energy Envelope Theory, treatment programs that recommend a steady increase in daily activity are discouraged because the person with [[ME/CFS]] may exceed the amount of energy available for that day, thereby initiating [[post-exertional malaise]] or an increase in symptoms. Those that stay within their daily &amp;quot;envelope&amp;quot; of energy, not only have fewer symptoms but often recover to a higher functioning level than those who don&#039;t.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The concept of staying within one&#039;s &amp;quot;energy envelope&amp;quot; is a similar [[pacing]] technique to the [[spoon theory]].&lt;br /&gt;
&lt;br /&gt;
==Patient experiences with the Envelope Theory==&lt;br /&gt;
*The [[Just ME]] blogger, Sally Burch, has written about self-pacing and [http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html the energy envelope] in a post called &#039;&#039;&amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot;&#039;&#039;.&amp;lt;ref&amp;gt;[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up not Boom &amp;amp; Bust]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Bruce Campbell, PhD, has included the Envelope Theory in chapter 7 of his manual, &#039;&#039;Recovery from Chronic Fatigue Syndrome: One Person&#039;s Story&#039;&#039;&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2013, Energy Conservation/[[Energy Envelope Theory|Envelope Theory]] Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596172/ (Full Text)]&lt;br /&gt;
*2008, The [[Energy Envelope Theory]] and [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/5276419_The_Energy_Envelope_Theory_and_myalgic_encephalomyelitischronic_fatigue_syndrome (Full text)]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot; - Sally Burch]&lt;br /&gt;
*[http://solvecfs.org/wp-content/uploads/2013/06/080505.pdf Solve ME/CFS Initiative - Managing Your Energy Envelope by Bruce Campbell (pdf)]&lt;br /&gt;
*[http://www.healthrising.org/blog/2013/05/17/coping-works-in-chronic-fatigue-syndrome-except-when-it-doesnt-study-suggests-large-group-gets-no-help/ Health Rising - Coping vs Energy Envelope in CFS]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Post-exertional malaise]]&lt;br /&gt;
*[[Pacing]]&lt;br /&gt;
*[[Pacing with a heart rate monitor]]&lt;br /&gt;
*[[Bed rest]]&lt;br /&gt;
*[[Spoon theory]]&lt;br /&gt;
*[[Graded exercise therapy]]&lt;br /&gt;
*[[Activity management based on 2-day cardiopulmonary exercise testing results]]&lt;br /&gt;
*[[Mindfulness]]&lt;br /&gt;
*[[Meditation]]&lt;br /&gt;
*[[Coping strategies]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason             | first1 = Leonard A.             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Muldowney         | first2 = Kathleen               | authorlink2 = &lt;br /&gt;
| last3   = Torres-Harding    | first3 = Susan                  | authorlink3 = Susan Torres-Harding&lt;br /&gt;
| title   = The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome&lt;br /&gt;
| journal = American Association of Occupational Health Nurses | volume = 56 | issue = 5 | page = 189-95&lt;br /&gt;
| date    = 2008&lt;br /&gt;
| doi     = 10.3928/08910162-20080501-06&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason          | first1 = LA          | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Brown          | first2 = M           | authorlink2 = Molly Brown&lt;br /&gt;
| last3   = Brown          | first3 = A           | authorlink3 = Abigail Brown&lt;br /&gt;
| last4   = Evans          | first4 = M           | authorlink4 = Meredyth Evans&lt;br /&gt;
| last5   = Flores         | first5 = S           | authorlink5 = &lt;br /&gt;
| last6   = Grant-Holler   | first6 = E           | authorlink6 = &lt;br /&gt;
| last7   = Sunnquist      | first7 = M           | authorlink7 = Madison Sunnquist&lt;br /&gt;
| title   = Energy conservation/envelope theory interventions&lt;br /&gt;
| journal = Fatigue: Biomedicine, Health &amp;amp; Behavior | volume = 1 | issue = 1-2 | page = 27-42&lt;br /&gt;
| date    = 2013&lt;br /&gt;
| doi     = 10.1080/21641846.2012.733602&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Management strategies]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37604</id>
		<title>Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37604"/>
		<updated>2018-08-15T16:09:58Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:ss&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pacing==&lt;br /&gt;
Pacing is one way for those diagnosed with myalgic encephalomyelitis (ME) to balance activity and rest and may even reduce symptom severity and the frequency of relapses&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite book|title=Pacing for People with M.E.|last=|first=|publisher=Action for M.E.|year=2013|isbn=|location=Bristol|pages=}}&amp;lt;/ref&amp;gt;. Day-to-day energy levels for those with ME are often unpredictable; however, pacing allows patients to assess their perceived energy levels on a daily basis (or in smaller time increments, as needed) and use that level to gauge their energy expenditure for the day. Pacing encourages [[ME/CFS|ME]] patients to accept their daily energy limitations and not exceed or fight them.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; Pacing is based on four main principles, and when practiced it can help to &amp;quot;support the body&#039;s natural recovery process&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&amp;quot; The four goals to pacing are activity, rest/relaxation, establishing a baseline, and increasing activity as you are able. &lt;br /&gt;
&lt;br /&gt;
Activity: every individual has his or her own definition of what it means to be active and therefore, &lt;br /&gt;
&lt;br /&gt;
==The Energy Envelope Theory==&lt;br /&gt;
The &#039;&#039;&#039;Energy Envelope Theory&#039;&#039;&#039; Some practitioners of the Energy Envelope Theory take the concept further by recommending that people with [[ME/CFS]] do less than their perceived energy would allow in order to have energy left over for recovery.&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Under the Energy Envelope Theory, treatment programs that recommend a steady increase in daily activity are discouraged because the person with [[ME/CFS]] may exceed the amount of energy available for that day, thereby initiating [[post-exertional malaise]] or an increase in symptoms. Those that stay within their daily &amp;quot;envelope&amp;quot; of energy, not only have fewer symptoms but often recover to a higher functioning level than those who don&#039;t.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The concept of staying within one&#039;s &amp;quot;energy envelope&amp;quot; is a similar [[pacing]] technique to the [[spoon theory]].&lt;br /&gt;
&lt;br /&gt;
==Patient experiences with the Envelope Theory==&lt;br /&gt;
*The [[Just ME]] blogger, Sally Burch, has written about self-pacing and [http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html the energy envelope] in a post called &#039;&#039;&amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot;&#039;&#039;.&amp;lt;ref&amp;gt;[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up not Boom &amp;amp; Bust]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Bruce Campbell, PhD, has included the Envelope Theory in chapter 7 of his manual, &#039;&#039;Recovery from Chronic Fatigue Syndrome: One Person&#039;s Story&#039;&#039;&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2013, Energy Conservation/[[Energy Envelope Theory|Envelope Theory]] Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot; /&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596172/ (Full Text)]&lt;br /&gt;
*2008, The [[Energy Envelope Theory]] and [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/5276419_The_Energy_Envelope_Theory_and_myalgic_encephalomyelitischronic_fatigue_syndrome (Full text)]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot; - Sally Burch]&lt;br /&gt;
*[http://solvecfs.org/wp-content/uploads/2013/06/080505.pdf Solve ME/CFS Initiative - Managing Your Energy Envelope by Bruce Campbell (pdf)]&lt;br /&gt;
*[http://www.healthrising.org/blog/2013/05/17/coping-works-in-chronic-fatigue-syndrome-except-when-it-doesnt-study-suggests-large-group-gets-no-help/ Health Rising - Coping vs Energy Envelope in CFS]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Post-exertional malaise]]&lt;br /&gt;
*[[Pacing]]&lt;br /&gt;
*[[Pacing with a heart rate monitor]]&lt;br /&gt;
*[[Bed rest]]&lt;br /&gt;
*[[Spoon theory]]&lt;br /&gt;
*[[Graded exercise therapy]]&lt;br /&gt;
*[[Activity management based on 2-day cardiopulmonary exercise testing results]]&lt;br /&gt;
*[[Mindfulness]]&lt;br /&gt;
*[[Meditation]]&lt;br /&gt;
*[[Coping strategies]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason             | first1 = Leonard A.             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Muldowney         | first2 = Kathleen               | authorlink2 = &lt;br /&gt;
| last3   = Torres-Harding    | first3 = Susan                  | authorlink3 = Susan Torres-Harding&lt;br /&gt;
| title   = The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome&lt;br /&gt;
| journal = American Association of Occupational Health Nurses | volume = 56 | issue = 5 | page = 189-95&lt;br /&gt;
| date    = 2008&lt;br /&gt;
| doi     = 10.3928/08910162-20080501-06&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason          | first1 = LA          | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Brown          | first2 = M           | authorlink2 = Molly Brown&lt;br /&gt;
| last3   = Brown          | first3 = A           | authorlink3 = Abigail Brown&lt;br /&gt;
| last4   = Evans          | first4 = M           | authorlink4 = Meredyth Evans&lt;br /&gt;
| last5   = Flores         | first5 = S           | authorlink5 = &lt;br /&gt;
| last6   = Grant-Holler   | first6 = E           | authorlink6 = &lt;br /&gt;
| last7   = Sunnquist      | first7 = M           | authorlink7 = Madison Sunnquist&lt;br /&gt;
| title   = Energy conservation/envelope theory interventions&lt;br /&gt;
| journal = Fatigue: Biomedicine, Health &amp;amp; Behavior | volume = 1 | issue = 1-2 | page = 27-42&lt;br /&gt;
| date    = 2013&lt;br /&gt;
| doi     = 10.1080/21641846.2012.733602&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Management strategies]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37602</id>
		<title>Energy Envelope Theory</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Energy_Envelope_Theory&amp;diff=37602"/>
		<updated>2018-08-15T15:39:23Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:name change&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==Pacing==&lt;br /&gt;
Pacing is one way for those diagnosed with [[myalgic encephalomyletis]] to balance activity and rest.&lt;br /&gt;
&lt;br /&gt;
==The Energy Envelope Theory==&lt;br /&gt;
The &#039;&#039;&#039;Energy Envelope Theory&#039;&#039;&#039; is a self-management tool to reduce symptom severity and the frequency of relapses. This theory suggests that because variations in day-to-day energy levels are often unpredictable in people with [[ME/CFS]], they are to assess their perceived energy levels on a daily basis (or in smaller time increments, as needed) and use that level to gauge their energy expenditure for the day. It encourages people with [[ME/CFS]] to accept their daily energy limitations and not exceed or fight them.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Some practitioners of the Energy Envelope Theory take the concept further by recommending that people with [[ME/CFS]] do less than their perceived energy would allow in order to have energy left over for recovery.&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Under the Energy Envelope Theory, treatment programs that recommend a steady increase in daily activity are discouraged because the person with [[ME/CFS]] may exceed the amount of energy available for that day, thereby initiating [[post-exertional malaise]] or an increase in symptoms. Those that stay within their daily &amp;quot;envelope&amp;quot; of energy, not only have fewer symptoms but often recover to a higher functioning level than those who don&#039;t.&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The concept of staying within one&#039;s &amp;quot;energy envelope&amp;quot; is a similar [[pacing]] technique to the [[spoon theory]].&lt;br /&gt;
&lt;br /&gt;
==Patient experiences with the Envelope Theory==&lt;br /&gt;
*The [[Just ME]] blogger, Sally Burch, has written about self-pacing and [http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html the energy envelope] in a post called &#039;&#039;&amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot;&#039;&#039;.&amp;lt;ref&amp;gt;[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up not Boom &amp;amp; Bust]&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Bruce Campbell, PhD, has included the Envelope Theory in chapter 7 of his manual, &#039;&#039;Recovery from Chronic Fatigue Syndrome: One Person&#039;s Story&#039;&#039;&amp;lt;ref&amp;gt;http://www.recoveryfromcfs.org/chapter7.htm&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
*2013, Energy Conservation/[[Energy Envelope Theory|Envelope Theory]] Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;/&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596172/ (Full Text)]&lt;br /&gt;
*2008, The [[Energy Envelope Theory]] and [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;/&amp;gt; [https://www.researchgate.net/publication/5276419_The_Energy_Envelope_Theory_and_myalgic_encephalomyelitischronic_fatigue_syndrome (Full text)]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[http://sallyjustme.blogspot.co.uk/2014/09/play-up-and-lay-up.html &amp;quot;Play-Up &amp;amp; Lay-Up&amp;quot; not &amp;quot;Boom &amp;amp; Bust&amp;quot; - Sally Burch]&lt;br /&gt;
*[http://solvecfs.org/wp-content/uploads/2013/06/080505.pdf Solve ME/CFS Initiative - Managing Your Energy Envelope by Bruce Campbell (pdf)]&lt;br /&gt;
*[http://www.healthrising.org/blog/2013/05/17/coping-works-in-chronic-fatigue-syndrome-except-when-it-doesnt-study-suggests-large-group-gets-no-help/ Health Rising - Coping vs Energy Envelope in CFS]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
*[[Post-exertional malaise]]&lt;br /&gt;
*[[Pacing]]&lt;br /&gt;
*[[Pacing with a heart rate monitor]]&lt;br /&gt;
*[[Bed rest]]&lt;br /&gt;
*[[Spoon theory]]&lt;br /&gt;
*[[Graded exercise therapy]]&lt;br /&gt;
*[[Activity management based on 2-day cardiopulmonary exercise testing results]]&lt;br /&gt;
*[[Mindfulness]]&lt;br /&gt;
*[[Meditation]]&lt;br /&gt;
*[[Coping strategies]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2008&amp;quot;&amp;gt;&lt;br /&gt;
{{Citation&lt;br /&gt;
| last1   = Jason             | first1 = Leonard A.             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Muldowney         | first2 = Kathleen               | authorlink2 = &lt;br /&gt;
| last3   = Torres-Harding    | first3 = Susan                  | authorlink3 = Susan Torres-Harding&lt;br /&gt;
| title   = The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome&lt;br /&gt;
| journal = American Association of Occupational Health Nurses | volume = 56 | issue = 5 | page = 189-95&lt;br /&gt;
| date    = 2008&lt;br /&gt;
| doi     = 10.3928/08910162-20080501-06&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason, 2013&amp;quot;&amp;gt;&lt;br /&gt;
{{Citation&lt;br /&gt;
| last1   = Jason          | first1 = LA          | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Brown          | first2 = M           | authorlink2 = Molly Brown&lt;br /&gt;
| last3   = Brown          | first3 = A           | authorlink3 = Abigail Brown&lt;br /&gt;
| last4   = Evans          | first4 = M           | authorlink4 = Meredyth Evans&lt;br /&gt;
| last5   = Flores         | first5 = S           | authorlink5 = &lt;br /&gt;
| last6   = Grant-Holler   | first6 = E           | authorlink6 = &lt;br /&gt;
| last7   = Sunnquist      | first7 = M           | authorlink7 = Madison Sunnquist&lt;br /&gt;
| title   = Energy conservation/envelope theory interventions&lt;br /&gt;
| journal = Fatigue: Biomedicine, Health &amp;amp; Behavior | volume = 1 | issue = 1-2 | page = 27-42&lt;br /&gt;
| date    = 2013&lt;br /&gt;
| doi     = 10.1080/21641846.2012.733602&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Potential treatments]]&lt;br /&gt;
[[Category:Management strategies]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=37497</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=37497"/>
		<updated>2018-08-13T17:59:25Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]] is the first step in a process known as [[cellular respiration]]. Glycolysis&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite web|url=http://dx.doi.org/10.3897/zookeys.578.7383.figure6|title=Figure 6 from: Matalin AV, Chikatunov VI (2016) The tiger beetles (Coleoptera, Carabidae, Cicindelinae) of Israel and adjacent lands. ZooKeys 578: 115-160. https://doi.org/10.3897/zookeys.578.7383|access-date=2018-08-10}}&amp;lt;/ref&amp;gt; is the process of breaking down (-lysis) glucose (glyco-), a sugar molecule that provides energy for the human body. Glucose&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt; is a polymer (made up of a chain of carbons) and therefore it takes multiple steps to break it down into usable energy. There are a total of ten steps in glycolysis. After the final step, the products of the broken down glucose molecule will enter the next step of cellular respiration.  &lt;br /&gt;
[[File:Glycolosis.png|left|thumb|Glycolysis steps 1-10 &amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;]]  &lt;br /&gt;
&lt;br /&gt;
[[File:Glucose molecule.png|thumb|&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite web|url=http://dx.doi.org/10.3897/zookeys.578.7383.figure6|title=Figure 6 from: Matalin AV, Chikatunov VI (2016) The tiger beetles (Coleoptera, Carabidae, Cicindelinae) of Israel and adjacent lands. ZooKeys 578: 115-160. https://doi.org/10.3897/zookeys.578.7383|access-date=2018-08-08}}&amp;lt;/ref&amp;gt;|172x172px]]&lt;br /&gt;
&amp;lt;p&amp;gt;&amp;lt;/p&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Glycolysis and myalgic encephalomyelitis==&lt;br /&gt;
Abnormal levels of glycolysis metabolites have been observed in patients with myalgic encephalomyelitis (ME)&amp;lt;ref&amp;gt;{{Cite journal|last=Nagy-Szakal|first=Dorottya|last2=Barupal|first2=Dinesh K.|last3=Lee|first3=Bohyun|last4=Che|first4=Xiaoyu|last5=Williams|first5=Brent L.|last6=Kahn|first6=Ellie J. R.|last7=Ukaigwe|first7=Joy E.|last8=Bateman|first8=Lucinda|last9=Klimas|first9=Nancy G.|date=2018-07-03|title=Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics|url=https://www.nature.com/articles/s41598-018-28477-9|journal=Scientific Reports|language=En|volume=8|issue=1|doi=10.1038/s41598-018-28477-9|issn=2045-2322}}&amp;lt;/ref&amp;gt;. This suggests that individuals with ME may experience abnormal regulation of glycolysis within their cells. &amp;lt;ref&amp;gt;{{Cite journal|last=Germain|first=Arnaud|last2=Ruppert|first2=David|last3=Levine|first3=Susan M.|last4=Hanson|first4=Maureen R.|date=2017|title=Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism|url=http://pubs.rsc.org/en/content/articlelanding/2017/mb/c6mb00600k/unauth#!divAbstract|journal=Molecular BioSystems|language=en|volume=13|issue=2|pages=371–379|doi=10.1039/C6MB00600K|issn=1742-206X}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Learn More==&lt;br /&gt;
*https://www.khanacademy.org/science/biology/cellular-respiration-and-fermentation/glycolysis/v/glycolysis&lt;br /&gt;
*http://www.sparknotes.com/biology/cellrespiration/glycolysis/ &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Cellular respiration]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=37496</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=37496"/>
		<updated>2018-08-13T17:57:22Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Anaerobic Respiration */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. Cellular respiration occurs within the cells [[mitochondria]] and cytoplasm (jelly-like substance that fills a cell). The general chemical formula for cellular respiration is glucose + oxygen --&amp;gt; carbon dioxide + water + energy&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite web|url=https://www.khanacademy.org/science/high-school-biology/hs-energy-and-transport/hs-cellular-respiration/a/hs-cellular-respiration-review|title=Cellular respiration review|website=Khan Academy|language=en|access-date=2018-08-13}}&amp;lt;/ref&amp;gt;. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
[[File:Overview of cellular respiration .png|center|frameless|500x500px|&amp;lt;ref&amp;gt;{{Cite web|url=https://www.google.com/search?site=imghp&amp;amp;tbm=isch&amp;amp;q=mitochondria&amp;amp;tbs=sur:fmc#imgdii=4O65l_IkZV7PAM:&amp;amp;imgrc=BiivvgDt2TBxSM:|title=mitochondria - Google Search|website=www.google.com|language=en|access-date=2018-08-13}}&amp;lt;/ref&amp;gt;]] &lt;br /&gt;
&lt;br /&gt;
==Anaerobic Respiration==&lt;br /&gt;
 &lt;br /&gt;
Organisms can also perform respiration without oxygen in a process called anaerobic respiration. In human cells, anaerobic respiration occurs through a process known as fermentation. If a cell does not have adequate oxygen to undergo cellular respiration then fermentation allows for [[glycolysis]] to continue to run. Anaerobic respiration is far less efficient at producing ATP than aerobic respiration&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Myalgic Encephalomyelitis and Cellular Respiration==&lt;br /&gt;
Paitents with myalgic encephalomyelitis (ME) have been observed to have an overall lower maximal cellular respiration capacity than control groups&amp;lt;ref&amp;gt;{{Cite journal|last=Tomas|first=Cara|last2=Brown|first2=Audrey|last3=Strassheim|first3=Victoria|last4=Elson|first4=Joanna|last5=Newton|first5=Julia|last6=Manning|first6=Philip|date=2017-10-24|title=Cellular bioenergetics is impaired in patients with chronic fatigue syndrome|url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186802|journal=PLOS ONE|language=en|volume=12|issue=10|pages=e0186802|doi=10.1371/journal.pone.0186802|issn=1932-6203|pmc=5655451|pmid=29065167}}&amp;lt;/ref&amp;gt;; This would mean that cell would be unable to keep up with its energy needs. Some studies have observed decreased production of ATP and other metabolic intermediates in patients with ME&amp;lt;ref&amp;gt;{{Cite journal|last=Nguyen|first=Thao|date=2017|title=Reduced glycolytic reserve in isolated natural killer cells from&lt;br /&gt;
Myalgic encephalomyelitis/chronic fatigue syndrome patients:&lt;br /&gt;
A preliminary investigation|url=http://apjai-journal.org/wp-content/uploads/2018/07/AP-011117-0188.pdf|journal=APJAI|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Naviaux|first=Robert K.|last2=Naviaux|first2=Jane C.|last3=Li|first3=Kefeng|last4=Bright|first4=A. Taylor|last5=Alaynick|first5=William A.|last6=Wang|first6=Lin|last7=Baxter|first7=Asha|last8=Nathan|first8=Neil|last9=Anderson|first9=Wayne|date=Sep 13, 2016|title=Metabolic features of chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/27573827|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=113|issue=37|pages=E5472–5480|doi=10.1073/pnas.1607571113|issn=1091-6490|pmc=5027464|pmid=27573827}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
*[[Glycolysis]]&lt;br /&gt;
*[[Citric acid cycle]]&lt;br /&gt;
*[[Electron transport chain]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=37493</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=37493"/>
		<updated>2018-08-13T17:44:36Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:minor&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. Cellular respiration occurs within the cells [[mitochondria]] and cytoplasm (jelly-like substance that fills a cell). The general chemical formula for cellular respiration is glucose + oxygen --&amp;gt; carbon dioxide + water + energy&amp;lt;ref&amp;gt;{{Cite web|url=https://www.khanacademy.org/science/high-school-biology/hs-energy-and-transport/hs-cellular-respiration/a/hs-cellular-respiration-review|title=Cellular respiration review|website=Khan Academy|language=en|access-date=2018-08-13}}&amp;lt;/ref&amp;gt;. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
[[File:Cellular respiration.gif|thumb|[[File:Screen Shot 2018-08-08 at 11.37.01 AM.png|202x202px|center|frameless|An overview of cellular respiration.&amp;lt;ref /&amp;gt;]]]]Anarobeic &lt;br /&gt;
&lt;br /&gt;
==Anaerobic Respiration==&lt;br /&gt;
 &lt;br /&gt;
Organisms can also perform respiration without oxygen in a process called anaerobic respiration. In human cells, anaerobic respiration occurs through a process known as fermentation. If a cell does not have adequate oxygen to undergo cellular respiration then fermentation allows for [[glycolysis]] to continue to run. Anaerobic respiration is far less efficient at producing ATP than aerobic respiration.&lt;br /&gt;
&lt;br /&gt;
==Myalgic Encephalomyelitis and Cellular Respiration==&lt;br /&gt;
Paitents with myalgic encephalomyelitis (ME) have been observed to have an overall lower maximal cellular respiration capacity than control groups&amp;lt;ref&amp;gt;{{Cite journal|last=Tomas|first=Cara|last2=Brown|first2=Audrey|last3=Strassheim|first3=Victoria|last4=Elson|first4=Joanna|last5=Newton|first5=Julia|last6=Manning|first6=Philip|date=2017-10-24|title=Cellular bioenergetics is impaired in patients with chronic fatigue syndrome|url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186802|journal=PLOS ONE|language=en|volume=12|issue=10|pages=e0186802|doi=10.1371/journal.pone.0186802|issn=1932-6203|pmc=5655451|pmid=29065167}}&amp;lt;/ref&amp;gt;; This would mean that cell would be unable to keep up with its energy needs. Some studies have observed decreased production of ATP and other metabolic intermediates in patients with ME&amp;lt;ref&amp;gt;{{Cite journal|last=Nguyen|first=Thao|date=2017|title=Reduced glycolytic reserve in isolated natural killer cells from&lt;br /&gt;
Myalgic encephalomyelitis/chronic fatigue syndrome patients:&lt;br /&gt;
A preliminary investigation|url=http://apjai-journal.org/wp-content/uploads/2018/07/AP-011117-0188.pdf|journal=APJAI|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Naviaux|first=Robert K.|last2=Naviaux|first2=Jane C.|last3=Li|first3=Kefeng|last4=Bright|first4=A. Taylor|last5=Alaynick|first5=William A.|last6=Wang|first6=Lin|last7=Baxter|first7=Asha|last8=Nathan|first8=Neil|last9=Anderson|first9=Wayne|date=Sep 13, 2016|title=Metabolic features of chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/27573827|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=113|issue=37|pages=E5472–5480|doi=10.1073/pnas.1607571113|issn=1091-6490|pmc=5027464|pmid=27573827}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
*[[Glycolysis]]&lt;br /&gt;
*[[Citric acid cycle]]&lt;br /&gt;
*[[Electron transport chain]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=37492</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=37492"/>
		<updated>2018-08-13T17:33:31Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:minor&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. Cellular respiration occurs in the [[mitochondria]], a small organelle inside of a cell. The general chemical formula for cellular respiration is glucose + oxygen --&amp;gt; carbon dioxide + water + energy&amp;lt;ref&amp;gt;{{Cite web|url=https://www.khanacademy.org/science/high-school-biology/hs-energy-and-transport/hs-cellular-respiration/a/hs-cellular-respiration-review|title=Cellular respiration review|website=Khan Academy|language=en|access-date=2018-08-13}}&amp;lt;/ref&amp;gt;. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
[[File:Cellular respiration.gif|thumb|[[File:Screen Shot 2018-08-08 at 11.37.01 AM.png|202x202px|center|frameless|An overview of cellular respiration.&amp;lt;ref /&amp;gt;]]]]&lt;br /&gt;
&lt;br /&gt;
==Fermentation==&lt;br /&gt;
Fermentation occurs when the cell does not have adequate oxygen to undergo cellular respiration. Fermentation is an alternative process to allow for [[glycolysis]] to continue even if there isn&#039;t oxygen present. &lt;br /&gt;
&lt;br /&gt;
==Myalgic Encephalomyelitis and Cellular Respiration==&lt;br /&gt;
Paitents with myalgic encephalomyelitis (ME) have been observed to have an overall lower maximal cellular respiration capacity than control groups&amp;lt;ref&amp;gt;{{Cite journal|last=Tomas|first=Cara|last2=Brown|first2=Audrey|last3=Strassheim|first3=Victoria|last4=Elson|first4=Joanna|last5=Newton|first5=Julia|last6=Manning|first6=Philip|date=2017-10-24|title=Cellular bioenergetics is impaired in patients with chronic fatigue syndrome|url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186802|journal=PLOS ONE|language=en|volume=12|issue=10|pages=e0186802|doi=10.1371/journal.pone.0186802|issn=1932-6203|pmc=5655451|pmid=29065167}}&amp;lt;/ref&amp;gt;; This would mean that cell would be unable to keep up with its energy needs. Some studies have observed decreased production of ATP and other metabolic intermediates in patients with ME&amp;lt;ref&amp;gt;{{Cite journal|last=Nguyen|first=Thao|date=2017|title=Reduced glycolytic reserve in isolated natural killer cells from&lt;br /&gt;
Myalgic encephalomyelitis/chronic fatigue syndrome patients:&lt;br /&gt;
A preliminary investigation|url=http://apjai-journal.org/wp-content/uploads/2018/07/AP-011117-0188.pdf|journal=APJAI|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Naviaux|first=Robert K.|last2=Naviaux|first2=Jane C.|last3=Li|first3=Kefeng|last4=Bright|first4=A. Taylor|last5=Alaynick|first5=William A.|last6=Wang|first6=Lin|last7=Baxter|first7=Asha|last8=Nathan|first8=Neil|last9=Anderson|first9=Wayne|date=Sep 13, 2016|title=Metabolic features of chronic fatigue syndrome|url=https://www.ncbi.nlm.nih.gov/pubmed/27573827|journal=Proceedings of the National Academy of Sciences of the United States of America|volume=113|issue=37|pages=E5472–5480|doi=10.1073/pnas.1607571113|issn=1091-6490|pmc=5027464|pmid=27573827}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
*[[Glycolysis]]&lt;br /&gt;
*[[Citric acid cycle]]&lt;br /&gt;
*[[Electron transport chain]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=37096</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=37096"/>
		<updated>2018-08-10T04:05:06Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Glycolysis and myalgic encephalomyelitis */ /&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]] is the first step in a process known as [[cellular respiration]]. Glycolysis&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite web|url=http://dx.doi.org/10.3897/zookeys.578.7383.figure6|title=Figure 6 from: Matalin AV, Chikatunov VI (2016) The tiger beetles (Coleoptera, Carabidae, Cicindelinae) of Israel and adjacent lands. ZooKeys 578: 115-160. https://doi.org/10.3897/zookeys.578.7383|access-date=2018-08-10}}&amp;lt;/ref&amp;gt; is the process of breaking down (-lysis) glucose (glyco-), a sugar molecule that provides energy in the human body. Glucose&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt; is a polymer (made up of a chain of carbons) and therefore it takes multiple steps to break it down into usable energy. There are a total of ten steps in glycolysis. After the final step, the products of the broken down glucose molecule will enter the next step of cellular respiration.  &lt;br /&gt;
[[File:Glycolosis.png|left|thumb|Glycolysis steps 1-10 &amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;]]  &lt;br /&gt;
&lt;br /&gt;
[[File:Glucose molecule.png|thumb|&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite web|url=http://dx.doi.org/10.3897/zookeys.578.7383.figure6|title=Figure 6 from: Matalin AV, Chikatunov VI (2016) The tiger beetles (Coleoptera, Carabidae, Cicindelinae) of Israel and adjacent lands. ZooKeys 578: 115-160. https://doi.org/10.3897/zookeys.578.7383|access-date=2018-08-08}}&amp;lt;/ref&amp;gt;|172x172px]]&lt;br /&gt;
&amp;lt;p&amp;gt;&amp;lt;/p&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Glycolysis and myalgic encephalomyelitis==&lt;br /&gt;
Abnormal levels of glycolysis metabolites have been observed in patients with myalgic encephalomyelitis (ME)&amp;lt;ref&amp;gt;{{Cite journal|last=Nagy-Szakal|first=Dorottya|last2=Barupal|first2=Dinesh K.|last3=Lee|first3=Bohyun|last4=Che|first4=Xiaoyu|last5=Williams|first5=Brent L.|last6=Kahn|first6=Ellie J. R.|last7=Ukaigwe|first7=Joy E.|last8=Bateman|first8=Lucinda|last9=Klimas|first9=Nancy G.|date=2018-07-03|title=Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics|url=https://www.nature.com/articles/s41598-018-28477-9|journal=Scientific Reports|language=En|volume=8|issue=1|doi=10.1038/s41598-018-28477-9|issn=2045-2322}}&amp;lt;/ref&amp;gt;. This suggests that individuals with ME may experience abnormal regulation of glycolysis within their cells. &amp;lt;ref&amp;gt;{{Cite journal|last=Germain|first=Arnaud|last2=Ruppert|first2=David|last3=Levine|first3=Susan M.|last4=Hanson|first4=Maureen R.|date=2017|title=Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism|url=http://pubs.rsc.org/en/content/articlelanding/2017/mb/c6mb00600k/unauth#!divAbstract|journal=Molecular BioSystems|language=en|volume=13|issue=2|pages=371–379|doi=10.1039/C6MB00600K|issn=1742-206X}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Learn More==&lt;br /&gt;
*https://www.khanacademy.org/science/biology/cellular-respiration-and-fermentation/glycolysis/v/glycolysis&lt;br /&gt;
*http://www.sparknotes.com/biology/cellrespiration/glycolysis/ &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Cellular respiration]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=37095</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=37095"/>
		<updated>2018-08-10T03:50:01Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* See Also */ //&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]] is the first step in a process known as [[cellular respiration]]. Glycolysis&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite web|url=http://dx.doi.org/10.3897/zookeys.578.7383.figure6|title=Figure 6 from: Matalin AV, Chikatunov VI (2016) The tiger beetles (Coleoptera, Carabidae, Cicindelinae) of Israel and adjacent lands. ZooKeys 578: 115-160. https://doi.org/10.3897/zookeys.578.7383|access-date=2018-08-10}}&amp;lt;/ref&amp;gt; is the process of breaking down (-lysis) glucose (glyco-), a sugar molecule that provides energy in the human body. Glucose&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt; is a polymer (made up of a chain of carbons) and therefore it takes multiple steps to break it down into usable energy. There are a total of ten steps in glycolysis. After the final step, the products of the broken down glucose molecule will enter the next step of cellular respiration.  &lt;br /&gt;
[[File:Glycolosis.png|left|thumb|Glycolysis steps 1-10 &amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;]]  &lt;br /&gt;
&lt;br /&gt;
[[File:Glucose molecule.png|thumb|&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite web|url=http://dx.doi.org/10.3897/zookeys.578.7383.figure6|title=Figure 6 from: Matalin AV, Chikatunov VI (2016) The tiger beetles (Coleoptera, Carabidae, Cicindelinae) of Israel and adjacent lands. ZooKeys 578: 115-160. https://doi.org/10.3897/zookeys.578.7383|access-date=2018-08-08}}&amp;lt;/ref&amp;gt;|172x172px]]&lt;br /&gt;
&amp;lt;p&amp;gt;&amp;lt;/p&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Glycolysis and myalgic encephalomyelitis== &lt;br /&gt;
==Learn More==&lt;br /&gt;
*https://www.khanacademy.org/science/biology/cellular-respiration-and-fermentation/glycolysis/v/glycolysis&lt;br /&gt;
*http://www.sparknotes.com/biology/cellrespiration/glycolysis/ &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Cellular respiration]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=File:Glycolosis.png&amp;diff=37094</id>
		<title>File:Glycolosis.png</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=File:Glycolosis.png&amp;diff=37094"/>
		<updated>2018-08-10T03:44:17Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Ten steps of glycolysis&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=File:Glycolysis.png&amp;diff=37080</id>
		<title>File:Glycolysis.png</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=File:Glycolysis.png&amp;diff=37080"/>
		<updated>2018-08-10T01:45:58Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Glycolysis&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36927</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36927"/>
		<updated>2018-08-08T20:30:40Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:pic&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]] is the first step in a process known as [[cellular respiration]]. Glycolysis is the process of breaking down (-lysis) glucose (glyco-), a sugar molecule that provides energy in the human body. Glucose&amp;lt;sup&amp;gt;[1]&amp;lt;/sup&amp;gt; is a polymer (made up of a chain of carbons) and therefore it takes multiple steps to break it down into usable energy. There are a total of ten steps in glycolysis. After the final step, the broken down glucose molecule will enter the next step of cellular respiration. &lt;br /&gt;
[[File:Glucose molecule.png|thumb|&amp;lt;ref&amp;gt;{{Cite web|url=http://dx.doi.org/10.3897/zookeys.578.7383.figure6|title=Figure 6 from: Matalin AV, Chikatunov VI (2016) The tiger beetles (Coleoptera, Carabidae, Cicindelinae) of Israel and adjacent lands. ZooKeys 578: 115-160. https://doi.org/10.3897/zookeys.578.7383|access-date=2018-08-08}}&amp;lt;/ref&amp;gt;]]&lt;br /&gt;
&amp;lt;p&amp;gt;&amp;lt;/p&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Learn More==&lt;br /&gt;
*https://www.khanacademy.org/science/biology/cellular-respiration-and-fermentation/glycolysis/v/glycolysis&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=File:Glucose_molecule.png&amp;diff=36926</id>
		<title>File:Glucose molecule.png</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=File:Glucose_molecule.png&amp;diff=36926"/>
		<updated>2018-08-08T20:28:39Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Glucose is a carbon polymer that requires an input of energy as well as several steps to produce usable energy.&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36925</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36925"/>
		<updated>2018-08-08T20:26:20Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:test&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]] is the first step in a process known as [[cellular respiration]]. Glycolysis is the process of breaking down (-lysis) glucose (glyco-), a sugar molecule that provides energy in the human body. Glucose is a polymer (made up of a chain of carbons) and therefore it takes multiple steps to break it down into usable energy. There are a total of ten steps in glycolysis. After the final step, the broken down glucose molecule will enter the next step of cellular respiration. &lt;br /&gt;
[[File:Example.jpg]] &amp;lt;p&amp;gt;&amp;lt;a href=&amp;quot;https://commons.wikimedia.org/wiki/File:D-glucose-chain-2D-Fischer.png#/media/File:D-glucose-chain-2D-Fischer.png&amp;quot;&amp;gt;&amp;lt;img src=&amp;quot;https://upload.wikimedia.org/wikipedia/commons/2/27/D-glucose-chain-2D-Fischer.png&amp;quot; alt=&amp;quot;D-glucose-chain-2D-Fischer.png&amp;quot;&amp;gt;&amp;lt;/a&amp;gt;&amp;lt;br&amp;gt;By &amp;lt;a href=&amp;quot;//commons.wikimedia.org/wiki/User:Benjah-bmm27&amp;quot; title=&amp;quot;User:Benjah-bmm27&amp;quot;&amp;gt;Ben&amp;lt;/a&amp;gt;; &amp;lt;a href=&amp;quot;//commons.wikimedia.org/wiki/User:Yikrazuul&amp;quot; title=&amp;quot;User:Yikrazuul&amp;quot;&amp;gt;Yikrazuul&amp;lt;/a&amp;gt; - &amp;lt;span class=&amp;quot;int-own-work&amp;quot; lang=&amp;quot;en&amp;quot;&amp;gt;Own work&amp;lt;/span&amp;gt;, Public Domain, &amp;lt;a href=&amp;quot;https://commons.wikimedia.org/w/index.php?curid=1019158&amp;quot;&amp;gt;Link&amp;lt;/a&amp;gt;&amp;lt;/p&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Learn More==&lt;br /&gt;
*https://www.khanacademy.org/science/biology/cellular-respiration-and-fermentation/glycolysis/v/glycolysis&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36924</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36924"/>
		<updated>2018-08-08T20:24:04Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:making&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]] is the first step in a process known as [[cellular respiration]]. Glycolysis is the process of breaking down (-lysis) glucose (glyco-), a sugar molecule that provides energy in the human body. Glucose is a polymer (made up of a chain of carbons) and therefore it takes multiple steps to break it down into usable energy. There are a total of ten steps in glycolysis. After the final step, the broken down glucose molecule will enter the next step of cellular respiration. &lt;br /&gt;
[[File:Example.jpg]]&lt;br /&gt;
&lt;br /&gt;
==Learn More==&lt;br /&gt;
*https://www.khanacademy.org/science/biology/cellular-respiration-and-fermentation/glycolysis/v/glycolysis&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36923</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36923"/>
		<updated>2018-08-08T20:12:25Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:hh&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]] is the first step in a process known as [cellular respiration]. Glycolysis is the process of breaking down (-lysis)[glucose] (glyco-), a sugar molecule that provides energy in the human body.&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36922</id>
		<title>Glycolysis</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Glycolysis&amp;diff=36922"/>
		<updated>2018-08-08T20:09:38Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:creating glycolysis&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Glycolysis]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36921</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36921"/>
		<updated>2018-08-08T20:08:35Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:author&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
[[File:Cellular respiration.gif|thumb|[[File:Screen Shot 2018-08-08 at 11.37.01 AM.png|202x202px|center|frameless|An overview of cellular respiration.&amp;lt;ref /&amp;gt;]]]]&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36920</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36920"/>
		<updated>2018-08-08T20:05:09Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:edit&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
[[File:Cellular respiration.gif|thumb|[[File:Screen Shot 2018-08-08 at 11.37.01 AM.png|thumb|101x101px]]]]&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36896</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36896"/>
		<updated>2018-08-08T17:38:40Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:gif&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
[[File:Cellular respiration.gif|thumb|[[File:Screen Shot 2018-08-08 at 11.37.01 AM.png|thumb]]]]&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36893</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36893"/>
		<updated>2018-08-08T17:35:37Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:gif&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
[[File:Cellular respiration.gif|Cellular respiration]]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36885</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36885"/>
		<updated>2018-08-08T17:01:11Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:CR&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from food into energy that can be used to carry out life processes. For the human body, usable energy comes in the form of a molecule called adenosine triphosphate ([[ATP]]). Cellular respiration is then the way in which the cells of the human body turn nutrients into ATP; this process can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36879</id>
		<title>Cellular respiration</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Cellular_respiration&amp;diff=36879"/>
		<updated>2018-08-08T16:49:40Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:1-4&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Cellular respiration&#039;&#039;&#039; is the set of metabolic reactions and processes that take place in the cells of organisms to convert biochemical energy from nutrients into adenosine triphosphate ([[ATP]])(this is the body&#039;s form of energy currency), and then release any waste products. Cellular respiration can be broken down into four core steps:&lt;br /&gt;
&lt;br /&gt;
# [[Glycolysis]]: the first step of cellular respiration is the breakdown of glucose into energy that the body can utilize.&lt;br /&gt;
# Oxidative decarboxylation of pyruvate: this step is done by an enzyme called the Pyruvate Dehydrogenase Complex (PDC).&lt;br /&gt;
# [[Citric acid cycle]] (Krebs cycle or TCA cycle): is a series of chemical reactions that take stored energy (proteins, fats, carbs) and convert them into ATP.&lt;br /&gt;
# [[Oxidative phosphorylation]]: the last step of cellular respiration uses a combination of several enzymes and oxygen to create a large quantity of ATP from the energy-dense molecules that were broken down in the previous steps. &lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
*[https://en.wikipedia.org/wiki/Cellular_respiration Wikipedia - Cellular respiration]&lt;br /&gt;
*[http://www.bozemanscience.com/cellular-respiration Cellular Respiration by Bozeman Science]&lt;br /&gt;
*[https://www.youtube.com/watch?v=00jbG_cfGuQ ATP &amp;amp; Respiration: Crash Course Biology]&lt;br /&gt;
*[https://www.youtube.com/watch?v=2f7YwCtHcgk Introduction to cellular respiration | Cellular respiration | Biology | Khan Academy]&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Mitochondria]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Biochemistry and cell biology]]&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32344</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32344"/>
		<updated>2018-06-20T20:57:38Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:pic&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
[[File:https://upload.wikimedia.org/wikipedia/commons/3/3b/Mast_cells_in_sinus_histiocytosis.jpg]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
*hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
*vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
*hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
*arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
*anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
*Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be unknown. In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and colleagues. These criteria suggest that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patient&#039;s symptoms must improve.  Thirdly, the patient should be tested for serum tryptase an enzyme secreted by mast cells during the peak of a symptomatic episode.   If tryptase is &amp;gt;15ng/mL the patient may have MCAD. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS), a heritable connective tissue disorder, [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production &amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease &amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; .&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[Magnesium]] deficiency has been seen to increase mast cell production in some cases; therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the patient should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental Treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
 [[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation. It is likely that each individual will have his or her personal triggers&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32343</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32343"/>
		<updated>2018-06-20T20:52:18Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Triggers */ .&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
*hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
*vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
*hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
*arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
*anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
*Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be unknown. In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and colleagues. These criteria suggest that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patient&#039;s symptoms must improve.  Thirdly, the patient should be tested for serum tryptase an enzyme secreted by mast cells during the peak of a symptomatic episode.   If tryptase is &amp;gt;15ng/mL the patient may have MCAD. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS), a heritable connective tissue disorder, [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production &amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease &amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; .&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[Magnesium]] deficiency has been seen to increase mast cell production in some cases; therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the patient should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental Treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
 [[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation. It is likely that each individual will have his or her personal triggers&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32342</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32342"/>
		<updated>2018-06-20T20:51:53Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Triggers */ /&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
*hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
*vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
*hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
*arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
*anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
*Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be unknown. In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and colleagues. These criteria suggest that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patient&#039;s symptoms must improve.  Thirdly, the patient should be tested for serum tryptase an enzyme secreted by mast cells during the peak of a symptomatic episode.   If tryptase is &amp;gt;15ng/mL the patient may have MCAD. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS), a heritable connective tissue disorder, [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production &amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease &amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; .&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[Magnesium]] deficiency has been seen to increase mast cell production in some cases; therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the patient should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental Treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
 [[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation. It is likely that each individual will have his or her personal triggers&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. .&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32339</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32339"/>
		<updated>2018-06-20T20:50:54Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Food Triggers */ //&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
*hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
*vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
*hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
*arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
*anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
*Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be unknown. In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and colleagues. These criteria suggest that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patient&#039;s symptoms must improve.  Thirdly, the patient should be tested for serum tryptase an enzyme secreted by mast cells during the peak of a symptomatic episode.   If tryptase is &amp;gt;15ng/mL the patient may have MCAD. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS), a heritable connective tissue disorder, [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production &amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease &amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; .&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[Magnesium]] deficiency has been seen to increase mast cell production in some cases; therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the patient should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental Treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
 [[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. It is likely that each individual will have his or her personal triggers1,2.&lt;br /&gt;
&lt;br /&gt;
===Environmental Triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32326</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32326"/>
		<updated>2018-06-20T20:41:19Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Comorbidities */ /&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
*hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
*vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
*hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
*arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
*anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
*Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be unknown. In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and colleagues. These criteria suggest that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patient&#039;s symptoms must improve.  Thirdly, the patient should be tested for serum tryptase an enzyme secreted by mast cells during the peak of a symptomatic episode.   If tryptase is &amp;gt;15ng/mL the patient may have MCAD. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS), a heritable connective tissue disorder, [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production &amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;.&lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease &amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; .&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[Magnesium]] deficiency has been seen to increase mast cell production in some cases; therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the patient should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental Treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
 [[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. It is likely that each individual will have his or her personal triggers1,2.&lt;br /&gt;
&lt;br /&gt;
===Food Triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to many or even most foods while others only to some.  &lt;br /&gt;
&lt;br /&gt;
===Environmental Triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32325</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32325"/>
		<updated>2018-06-20T20:39:42Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:chronic&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
*hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
*vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
*hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
*arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
*anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
*Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be unknown. In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and colleagues. These criteria suggest that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patient&#039;s symptoms must improve.  Thirdly, the patient should be tested for serum tryptase an enzyme secreted by mast cells during the peak of a symptomatic episode.   If tryptase is &amp;gt;15ng/mL the patient may have MCAD. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.&lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS), a heritable connective tissue disorder, [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production6,7. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[Magnesium]] deficiency has been seen to increase mast cell production in some cases; therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the patient should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental Treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
 [[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. It is likely that each individual will have his or her personal triggers1,2.&lt;br /&gt;
&lt;br /&gt;
===Food Triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to many or even most foods while others only to some.  &lt;br /&gt;
&lt;br /&gt;
===Environmental Triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32324</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32324"/>
		<updated>2018-06-20T20:36:40Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:chronic&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
*hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
*vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
*hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
*arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
*anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
*Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be unknown. In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and colleagues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. These criteria suggest that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patient&#039;s symptoms must improve.  Thirdly, the patient should be tested for serum tryptase an enzyme secreted by mast cells during the peak of a symptomatic episode.   If tryptase is &amp;gt;20ng/mL the patient may have MCAD. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested4. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS), a heritable connective tissue disorder, [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production6,7. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[Magnesium]] deficiency has been seen to increase mast cell production in some cases; therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the patient should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental Treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
 [[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. It is likely that each individual will have his or her personal triggers1,2.&lt;br /&gt;
&lt;br /&gt;
===Food Triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to many or even most foods while others only to some.  &lt;br /&gt;
&lt;br /&gt;
===Environmental Triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32307</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32307"/>
		<updated>2018-06-19T23:14:11Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Signs and Symptoms */x&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might wax and wane&lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
-hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
-vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
-hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
-arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
-anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
-Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be idiopathic (unknown). In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and collegues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. This criteria suggests that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patients symptoms must improve.  Thirdly, the patient should be tested for serum tryptase (an enzyme secreted by mast cells) levels during a peak of a symptomatic episode. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS) or [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[magnesium]] deficiency has been seen to increase mast cell production in some cases; Therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the paitent should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;[[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston but their focus is on mast cell disorders as opposed to mast cell activation disorders. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. It is likely that each individual will have his or her personal triggers.&lt;br /&gt;
&lt;br /&gt;
===Food triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to all foods while others only to some. &lt;br /&gt;
&lt;br /&gt;
Some foods containing high levels of histamine include salmon, avocado, red wine, strawberries, raspberries, cherries, spinach, and leftovers (especially fish and meat). Anything aged or process will be high in histamine and should be avoided (processed meats, aged cheeses, 36-hour chicken bone broth, etc.) &lt;br /&gt;
&lt;br /&gt;
===Environmental triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://thelowhistaminechef.com/ Low Histamine Chef] &lt;br /&gt;
*[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32306</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32306"/>
		<updated>2018-06-19T23:12:35Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:add&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a source that is not related to a disease. MCAD is characterized by symptoms that result from overactive mast cells, which are a cell in the immune system that produces histamine.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore may be confused. It is also possible to have ME and MCAS disorders simultaneously.  &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. &lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might disappear and then suddenly reappear. &lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
-hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
-vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
-hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
-arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
-anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
-Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be idiopathic (unknown). In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and collegues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. This criteria suggests that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patients symptoms must improve.  Thirdly, the patient should be tested for serum tryptase (an enzyme secreted by mast cells) levels during a peak of a symptomatic episode. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS) or [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[magnesium]] deficiency has been seen to increase mast cell production in some cases; Therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the paitent should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;[[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston but their focus is on mast cell disorders as opposed to mast cell activation disorders. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. It is likely that each individual will have his or her personal triggers.&lt;br /&gt;
&lt;br /&gt;
===Food triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to all foods while others only to some. &lt;br /&gt;
&lt;br /&gt;
Some foods containing high levels of histamine include salmon, avocado, red wine, strawberries, raspberries, cherries, spinach, and leftovers (especially fish and meat). Anything aged or process will be high in histamine and should be avoided (processed meats, aged cheeses, 36-hour chicken bone broth, etc.) &lt;br /&gt;
&lt;br /&gt;
===Environmental triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://thelowhistaminechef.com/ Low Histamine Chef] &lt;br /&gt;
*[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32046</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32046"/>
		<updated>2018-06-13T20:18:46Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Common Treatments */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a non-pathogenic source. All MCAD are characterized by similar symptoms that result from overactive mast cells.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore is often confused. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might disappear and then suddenly reappear. &lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
-hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
-vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
-hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
-arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
-anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
-Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be idiopathic (unknown). In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and collegues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. This criteria suggests that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patients symptoms must improve.  Thirdly, the patient should be tested for serum tryptase (an enzyme secreted by mast cells) levels during a peak of a symptomatic episode. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS) or [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. [[magnesium]] deficiency has been seen to increase mast cell production in some cases; Therefore magnesium supplementation may be helpful in controlling mast cell division&amp;lt;ref&amp;gt;{{Cite journal|last=Takemoto|first=S|date=|title=Magnesium deficiency induces the emergence of mast cells in the liver of rats.|url=|journal=J Nutr Sci Vitaminol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. &lt;br /&gt;
&lt;br /&gt;
Over the counter antihistamines such as Allegra, Zyrtec, or Claritin are a common treatment for MCAD. It is recommended that the paitent should consult a physician for secondary symptom treatment or targeted mast cell therapies&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2016|title=Pharmacological treatment options for mast cell activation disease|url=|journal=Naunyn Schmiedebergs Arch Pharmacol.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Some patients also use herbal antihistamine supplements such as [[quercetin]] or [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine. &lt;br /&gt;
&lt;br /&gt;
=== Experimental treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant urticaria, an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;[[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic urticaria.&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston but their focus is on mast cell disorders as opposed to mast cell activation disorders. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. It is likely that each individual will have his or her personal triggers.&lt;br /&gt;
&lt;br /&gt;
===Food triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to all foods while others only to some. &lt;br /&gt;
&lt;br /&gt;
Some foods containing high levels of histamine include salmon, avocado, red wine, strawberries, raspberries, cherries, spinach, and leftovers (especially fish and meat). Anything aged or process will be high in histamine and should be avoided (processed meats, aged cheeses, 36-hour chicken bone broth, etc.) &lt;br /&gt;
&lt;br /&gt;
===Environmental triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://thelowhistaminechef.com/ Low Histamine Chef] &lt;br /&gt;
*[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32045</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32045"/>
		<updated>2018-06-13T20:00:47Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Common Treatments */ mg&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a non-pathogenic source. All MCAD are characterized by similar symptoms that result from overactive mast cells.&amp;lt;ref&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore is often confused. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might disappear and then suddenly reappear. &lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
-hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
-vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
-hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
-arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
-anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
-Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be idiopathic (unknown). In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and collegues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. This criteria suggests that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patients symptoms must improve.  Thirdly, the patient should be tested for serum tryptase (an enzyme secreted by mast cells) levels during a peak of a symptomatic episode. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS) or [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;johnston1992&amp;quot;&amp;gt;{{Citation| issn = 0731-5724| volume = 11| issue = 2| pages = 172–176| last1 = Johnston| first1 = C. S.| last2 = Martin| first2 = L. J.| last3 = Cai| first3 = X.| title = Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis| journal = Journal of the American College of Nutrition| date = April 1992| pmid = 1578094}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.[[magnesium]] deficiencey has been seen to increase mast cell production in some cases; Therefore magnesium supplementation may be helpful in controling mast cell divsion Takemoto S, Yamamoto A, Tomonaga S, Funaba M, Matsui T. Magnesium deficiency induces the emergence of mast cells in the liver of rats. J Nutr Sci Vitaminol (Tokyo) 2013;59:560–563.&lt;br /&gt;
&lt;br /&gt;
Over the counter [[Antihistamine|antihistamines]] such as [[Allegra]] and [[Zyrtec]] and [[Claritin]] are a common treatment for MCAD.{{Citation needed}} Some patients also use herbal antihistamines and supplements such as [[quercetin]] and [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine.{{Citation needed}} &lt;br /&gt;
&lt;br /&gt;
Dr. Afrin highly recommends [[sodium cromolyn]] in compounded oral form, as well as the use of the anthistamine and mast cell stabilizer [[ketotifen]].{{Citation needed}} Both of those medications are available over the counter only as eye drops and must be specially requested from pharmacies. Other [[antihistamines]] include [[hydroxyzine]] and [[levocetirizine]]. Many patients have also found the moderate use of [[benzodiazepines]] like [[lorazepam]] to be effective.{{Citation needed}} &lt;br /&gt;
&lt;br /&gt;
=== Experimental treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant [[urticaria]], an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic [[urticaria]].&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston but their focus is on mast cell disorders as opposed to mast cell activation disorders. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation.&lt;br /&gt;
&lt;br /&gt;
===Food triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to all foods while others only to some. &lt;br /&gt;
&lt;br /&gt;
Some foods containing high levels of histamine include salmon, avocado, red wine, strawberries, raspberries, cherries, spinach, and leftovers (especially fish and meat). Anything aged or process will be high in histamine and should be avoided (processed meats, aged cheeses, 36-hour chicken bone broth, etc.) &lt;br /&gt;
&lt;br /&gt;
===Environmental triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://thelowhistaminechef.com/ Low Histamine Chef] &lt;br /&gt;
*[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32044</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32044"/>
		<updated>2018-06-13T19:51:19Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:cc&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a non-pathogenic source. All MCAD are characterized by similar symptoms that result from overactive mast cells.&amp;lt;ref&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore is often confused. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might disappear and then suddenly reappear. &lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
-hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
-vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
-hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
-arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
-anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
-Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be idiopathic (unknown). In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and collegues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. This criteria suggests that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patients symptoms must improve.  Thirdly, the patient should be tested for serum tryptase (an enzyme secreted by mast cells) levels during a peak of a symptomatic episode. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS) or [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
== Common Treatments ==&lt;br /&gt;
&lt;br /&gt;
[[Vitamin C]] has been noted to reduce blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;johnston1992&amp;quot;&amp;gt;{{Citation| issn = 0731-5724| volume = 11| issue = 2| pages = 172–176| last1 = Johnston| first1 = C. S.| last2 = Martin| first2 = L. J.| last3 = Cai| first3 = X.| title = Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis| journal = Journal of the American College of Nutrition| date = April 1992| pmid = 1578094}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;.[[magnesium]], a cofactor for producing DAO.&lt;br /&gt;
&lt;br /&gt;
Over the counter [[Antihistamine|antihistamines]] such as [[Allegra]] and [[Zyrtec]] and [[Claritin]] are a common treatment for MCAD.{{Citation needed}} Some patients also use herbal antihistamines and supplements such as [[quercetin]] and [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine.{{Citation needed}} &lt;br /&gt;
&lt;br /&gt;
Dr. Afrin highly recommends [[sodium cromolyn]] in compounded oral form, as well as the use of the anthistamine and mast cell stabilizer [[ketotifen]].{{Citation needed}} Both of those medications are available over the counter only as eye drops and must be specially requested from pharmacies. Other [[antihistamines]] include [[hydroxyzine]] and [[levocetirizine]]. Many patients have also found the moderate use of [[benzodiazepines]] like [[lorazepam]] to be effective.{{Citation needed}} &lt;br /&gt;
&lt;br /&gt;
=== Experimental treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant [[urticaria]], an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic [[urticaria]].&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston but their focus is on mast cell disorders as opposed to mast cell activation disorders. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation.&lt;br /&gt;
&lt;br /&gt;
===Food triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to all foods while others only to some. &lt;br /&gt;
&lt;br /&gt;
Some foods containing high levels of histamine include salmon, avocado, red wine, strawberries, raspberries, cherries, spinach, and leftovers (especially fish and meat). Anything aged or process will be high in histamine and should be avoided (processed meats, aged cheeses, 36-hour chicken bone broth, etc.) &lt;br /&gt;
&lt;br /&gt;
===Environmental triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://thelowhistaminechef.com/ Low Histamine Chef] &lt;br /&gt;
*[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32019</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32019"/>
		<updated>2018-06-13T00:07:47Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:/* Comorbidities */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a non-pathogenic source. All MCAD are characterized by similar symptoms that result from overactive mast cells.&amp;lt;ref&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore is often confused. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might disappear and then suddenly reappear. &lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
-hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
-vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
-hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
-arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
-anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
-Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be idiopathic (unknown). In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and collegues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. This criteria suggests that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patients symptoms must improve.  Thirdly, the patient should be tested for serum tryptase (an enzyme secreted by mast cells) levels during a peak of a symptomatic episode. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often diagnosed in patients that have been previously diagnosed with [[Ehlers-Danlos syndrome]] (EDS) or [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;. Both of these conditions are also commonly co-morbid with [[ME/CFS|ME]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased tryptase production. &lt;br /&gt;
&lt;br /&gt;
An extra copy of the gene TPSAB1 has been noted as a possible cause for increased tryptase production&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt; It has also been implicated in many other immunological diseases including autism, [[fibromyalgia]], and chronic Lyme disease.&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
=== Common treatments ===&lt;br /&gt;
Over the counter [[Antihistamine|antihistamines]] such as [[Allegra]] and [[Zyrtec]] and [[Claritin]] are a common treatment for MCAD.{{Citation needed}} Some patients also use herbal antihistamines and supplements such as [[quercetin]] and [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine.{{Citation needed}} [[Vitamin C]], which reduces blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;johnston1992&amp;quot;&amp;gt;{{Citation| issn = 0731-5724| volume = 11| issue = 2| pages = 172–176| last1 = Johnston| first1 = C. S.| last2 = Martin| first2 = L. J.| last3 = Cai| first3 = X.| title = Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis| journal = Journal of the American College of Nutrition| date = April 1992| pmid = 1578094}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;, may also be helpful along with [[magnesium]], a cofactor for producing DAO.&lt;br /&gt;
&lt;br /&gt;
Dr. Afrin highly recommends [[sodium cromolyn]] in compounded oral form, as well as the use of the anthistamine and mast cell stabilizer [[ketotifen]].{{Citation needed}} Both of those medications are available over the counter only as eye drops and must be specially requested from pharmacies. Other [[antihistamines]] include [[hydroxyzine]] and [[levocetirizine]]. Many patients have also found the moderate use of [[benzodiazepines]] like [[lorazepam]] to be effective.{{Citation needed}} &lt;br /&gt;
&lt;br /&gt;
=== Experimental treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant [[urticaria]], an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic [[urticaria]].&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston but their focus is on mast cell disorders as opposed to mast cell activation disorders. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation.&lt;br /&gt;
&lt;br /&gt;
===Food triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to all foods while others only to some. &lt;br /&gt;
&lt;br /&gt;
Some foods containing high levels of histamine include salmon, avocado, red wine, strawberries, raspberries, cherries, spinach, and leftovers (especially fish and meat). Anything aged or process will be high in histamine and should be avoided (processed meats, aged cheeses, 36-hour chicken bone broth, etc.) &lt;br /&gt;
&lt;br /&gt;
===Environmental triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://thelowhistaminechef.com/ Low Histamine Chef] &lt;br /&gt;
*[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32014</id>
		<title>Mast cell activation syndrome</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mast_cell_activation_syndrome&amp;diff=32014"/>
		<updated>2018-06-12T22:51:01Z</updated>

		<summary type="html">&lt;p&gt;Juliajt:diagnosis&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&#039;&#039;&#039;Mast cell activation disorder&#039;&#039;&#039; (MCAD) is a spectrum of disorders that involve an immune response from a non-pathogenic source. All MCAD are characterized by similar symptoms that result from overactive mast cells.&amp;lt;ref&amp;gt;{{Cite journal|last=Frieri|first=Marianne|date=2015|title=Mast Cell Activation Syndrome|url=https://link.springer.com/article/10.1007%2Fs12016-015-8487-6|journal=Allergy and Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. Symptoms of MCAD are generally similar although each disorder can be characterized individually. &lt;br /&gt;
Primary MCAD is a condition in which too many mast cells are being created by the bone marrow&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite journal|last=Akim|first=Cem|date=August 2017|title=Mast Cell Activation Syndromes|url=|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;; Secondary MCAD would be that the body&#039;s [[mast cell]]s are being created normally, but are over-responsive to dietary or environmental triggers. Both of these situations might lead an individual to have excess [[histamine]] in circulation. Excess histamine can cause severe inflammation and a wide variety of symptoms. Almost any organ system in the body can be affected by MCAD&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;. Because a variety of symptoms can be present MCAD is commonly misdiagnosed. The symptoms of MCAD can also be very similar to that of [[myalgic encephalomyelitis]] (ME) and therefore is often confused. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Signs and Symptoms==&lt;br /&gt;
&lt;br /&gt;
A confounding element in diagnosing MCAD is that signs and symptoms occur in almost all areas of the body. The symptoms might disappear and then suddenly reappear. &lt;br /&gt;
&lt;br /&gt;
Most patients experience fatigue, fevers, and sensitivity to individualized environmental &amp;quot;triggers.&amp;quot; Other commonly identified signs and symptoms are as follows&amp;lt;ref&amp;gt;{{Cite journal|last=Molderings|first=G|date=2011|title=Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/|journal=J Hematol Oncol|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
-hot flashes, irregular heartbeat, high or low blood pressure (hypotension and/or hypertension)&lt;br /&gt;
&lt;br /&gt;
-vertigo, dizziness, forgetfulness, depression or anxiety, headaches, insomnia, restlessness&lt;br /&gt;
&lt;br /&gt;
-hives or other visible skin rashes&lt;br /&gt;
&lt;br /&gt;
-arthritis, muscle pain, bone pain, osteoporosis/osteopenia&lt;br /&gt;
&lt;br /&gt;
-anaphylaxis (a severe allergic reaction)&lt;br /&gt;
&lt;br /&gt;
-Malabsorption and gastrointestinal distress leading to low iron and low Vitamin D and low B12&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
MCAD can be difficult to diagnose as the cause of the syndrome is still considered to be idiopathic (unknown). In 2010, a criteria for diagnosing MCAS was proposed by Dr. Cem Akin and collegues&amp;lt;ref&amp;gt;{{Cite journal|last=Akin|first=Cem|date=2010|title=Mast Cell Activation Syndrome: Proposed Diagnostic Criteria|url=|journal=J Allergy and Clinical Immuno|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;. This criteria suggests that two or more organ systems must be affected; this can include gastrointestinal, cardiovascular, skin, or respiratory. If given histamine or mast cell therapy, the patients symptoms must improve.  Thirdly, the patient should be tested for serum tryptase (an enzyme secreted by mast cells) levels during a peak of a symptomatic episode. Urine and blood tests should be collected more than once to confirm a positive diagnosis. Prostaglandin and histamine levels can be also be tested. &lt;br /&gt;
 &lt;br /&gt;
==Comorbidities==&lt;br /&gt;
&lt;br /&gt;
MCAD is often found in patients with [[Ehlers-Danlos syndrome]] (EDS) and [[postural orthostatic tachycardia syndrome]] (POTS), a form of [[orthostatic intolerance]]&amp;lt;ref&amp;gt;Milner, Joshua, Dr. &amp;quot;Research Update: POTS, EDS, MCAS Genetics.&amp;quot; 2015 Dysautonomia International Conference &amp;amp; CME. Washington DC. Dysautonomia International Research Update: POTS, EDS, MCAS Genetics. Web. &amp;lt;https://vimeo.com/142039306&amp;gt;.&amp;lt;/ref&amp;gt;, two conditions commonly co-morbid with [[ME/CFS]]. The overlap between EDS, POTS, and MCAD is thought to be due to increased [[tryptase]] production owing to an extra copy of a gene called [[TPSAB1]]&#039;&#039;.&#039;&#039;&amp;lt;ref&amp;gt;{{Cite news|url=http://mentalfloss.com/article/87506/one-gene-mutation-links-three-mysterious-debilitating-diseases|title=One Gene Mutation Links Three Mysterious, Debilitating Diseases|last=Horowitz|first=Kate|date=October 17, 2016|work=Mental Floss|archive-url=|archive-date=|dead-url=|access-date=April 22, 2018}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|url=http://www.jacionline.org/article/S0091-6749(14)02927-3/abstract|title=A New Disease Cluster: Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome, and Ehlers-Danlos Syndrome|last=Cheung|first=Ingrid|date=February 2015|journal=The Journal of Allergy and Clinical Immunology|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
It has been implicated in many other immunological diseases including [[autism]], [[fibromyalgia]], and [[chronic Lyme disease]].&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
&lt;br /&gt;
=== Common treatments ===&lt;br /&gt;
Over the counter [[Antihistamine|antihistamines]] such as [[Allegra]] and [[Zyrtec]] and [[Claritin]] are a common treatment for MCAD.{{Citation needed}} Some patients also use herbal antihistamines and supplements such as [[quercetin]] and [[diamine oxidase]] (DAO), an enzyme normally produced by the body that breaks down histamine.{{Citation needed}} [[Vitamin C]], which reduces blood histamine levels&amp;lt;ref name=&amp;quot;clemetson1980&amp;quot;&amp;gt;{{Citation| issn = 0022-3166| volume = 110| issue = 4| pages = 662–668| last = Clemetson| first = C. A.| title = Histamine and ascorbic acid in human blood| journal = The Journal of Nutrition| date = April 1980| pmid = 7365537}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;johnston1992&amp;quot;&amp;gt;{{Citation| issn = 0731-5724| volume = 11| issue = 2| pages = 172–176| last1 = Johnston| first1 = C. S.| last2 = Martin| first2 = L. J.| last3 = Cai| first3 = X.| title = Antihistamine effect of supplemental ascorbic acid and neutrophil chemotaxis| journal = Journal of the American College of Nutrition| date = April 1992| pmid = 1578094}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite journal|last=Yazdani|first=Shaik|date=2016|title=Relationship Between Vitamin C, Mast Cells, and Inflammation|url=https://www.omicsonline.org/open-access/relationship-between-vitamin-c-mast-cells-and-inflammation-2155-9600-1000456.php?aid=66895|journal=J Nutr Food Sci.|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;, may also be helpful along with [[magnesium]], a cofactor for producing DAO.&lt;br /&gt;
&lt;br /&gt;
Dr. Afrin highly recommends [[sodium cromolyn]] in compounded oral form, as well as the use of the anthistamine and mast cell stabilizer [[ketotifen]].{{Citation needed}} Both of those medications are available over the counter only as eye drops and must be specially requested from pharmacies. Other [[antihistamines]] include [[hydroxyzine]] and [[levocetirizine]]. Many patients have also found the moderate use of [[benzodiazepines]] like [[lorazepam]] to be effective.{{Citation needed}} &lt;br /&gt;
&lt;br /&gt;
=== Experimental treatments ===&lt;br /&gt;
There is some limited evidence that [[sauna]] may be useful in antihistamine resistant [[urticaria]], an allergic skin condition that involves mast cell activation and the production of excess histamine.&amp;lt;ref&amp;gt;{{Cite journal|last=Magen|first=Eli|date=2014|title=Beneficial Effect of Sauna Therapy on Severe Antihistamine-Resistant Chronic Urticaria|url=http://www.espalibrary.eu/media/filer_public/5e/18/5e180886-9aa4-4d26-9ff2-158689f0fbcc/38034.pdf|journal=Israeli Medical Association Journal|volume=|pages=|via=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Omalizumab]] has been proposed as a possible mast cell stabilizer and is used in allergic asthma and chronic [[urticaria]].&lt;br /&gt;
&lt;br /&gt;
===Doctors===&lt;br /&gt;
&lt;br /&gt;
There are a very few mast cell specialists working in the United States. An expert is Dr. [[Lawrence Afrin]] formerly at the University of Minnesota now in in Armonk, NY. Drs Clem Akin and Mariana Castells run a mastocytosis clinic at Brigham and Women&#039;s in Boston but their focus is on mast cell disorders as opposed to mast cell activation disorders. More integrative doctors are beginning to be aware of mast cell activation syndrome, but it remains elusive in both treatment and diagnosis.&lt;br /&gt;
&lt;br /&gt;
==Triggers==&lt;br /&gt;
&lt;br /&gt;
Emotional or physical stress, many foods, and environmental factors can trigger mast cell degranulation.&lt;br /&gt;
&lt;br /&gt;
===Food triggers===&lt;br /&gt;
&lt;br /&gt;
There are many food lists detailing common triggers but individual reactions will vary. Some individuals will react to all foods while others only to some. &lt;br /&gt;
&lt;br /&gt;
Some foods containing high levels of histamine include salmon, avocado, red wine, strawberries, raspberries, cherries, spinach, and leftovers (especially fish and meat). Anything aged or process will be high in histamine and should be avoided (processed meats, aged cheeses, 36-hour chicken bone broth, etc.) &lt;br /&gt;
&lt;br /&gt;
===Environmental triggers===&lt;br /&gt;
&lt;br /&gt;
[[Mold]], air pollution, and car exhaust are common environmental triggers.&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://thelowhistaminechef.com/ Low Histamine Chef] &lt;br /&gt;
*[https://en.wikipedia.org/wiki/Mast_cell_activation_syndrome Mast cell activation syndrome], Wikipedia&lt;br /&gt;
*Molderings GJ, Brettner S, Homann J, Afrin LB. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options. Journal of Hematology &amp;amp; Oncology. 2011;4:10. doi:10.1186/1756-8722-4-10. (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/)&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mast cell]]&lt;br /&gt;
*[[Theoharis Theoharides]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&lt;br /&gt;
[[Category:Diagnoses]]&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Juliajt</name></author>
	</entry>
</feed>